Extrapyramidal and movement disorders

G6_XTRAPYR

basal ganglia disease: A disease involving the basal ganglia.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G20-G26 Cause of death: ICD-10 — G20-G26 2 out of 7 registries used, show all original rules.	13516
4. Check minimum number of events None	13516
5. Include endpoints G6_PARKINSON G6_PARKSCND G6_BASDEGENOTH G6_DYSTON G6_XTRAPYROTH	16714
6. Filter based on genotype QC (FinnGen only)	16714

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	G6_XTRAPYR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_PARKINSON\|G6_PARKSCND\|G6_BASDEGENOTH\|G6_DYSTON\|G6_XTRAPYROTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G2
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G2
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Extrapyramidal and movement disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	134703	69914	63238
Only index persons	105762	56932	48830
Unadjusted period prevalence (%)
Whole population	1.89	2.00	1.77
Only index persons	1.99	2.09	1.86
Median age at first event (years)
Whole population	67.76	67.76	67.69
Only index persons	66.50	66.48	66.53

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16714	9015	7699
Unadjusted period prevalence (%)	3.22	3.07	3.39
Median age at first event (years)	64.30	61.88	67.13

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
14643: Matched controls
146427

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C07AA05

ATC

propranolol; systemic

3.9

323.0

4450

14699

G25.2

ICD-10 Finland

Other specified forms of tremor

73.7

323.0

493

N04BD01

ATC

selegiline; oral

290.0

323.0

1829

N04BX02

ATC

entacapone; oral

+∞

323.0

413

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

267.2

323.0

1180

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

165.2

323.0

4618

407

N04BC04

ATC

ropinirole; oral

142.7

323.0

1242

N04BC09

ATC

rotigotine; transdermal

192.4

323.0

448

N03AE01

ATC

clonazepam; systemic

9.6

323.0

2603

3217

N87

ICPC

Parkinsonism

164.4

323.0

1479

100

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

323.0

4443

G24.3

ICD-10 Finland

Spasmodic torticollis

133.5

323.0

1042

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.2

323.0

1741

4525

N05AH03

ATC

olanzapine; systemic

4.8

323.0

1329

3000

N04AA02

ATC

biperiden; systemic

15.2

323.0

953

669

N03AX12

ATC

gabapentin; oral

2.9

323.0

3135

12616

G24.8

ICD-10 Finland

Other dystonia

1295.4

323.0

379

N04BC05

ATC

pramipexole; oral

16.7

323.0

4776

4121

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

437.8

323.0

344

N04BD02

ATC

rasagiline; oral

1334.3

323.0

879

N06AX11

ATC

mirtazapine; oral

2.2

323.0

5300

29987

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

323.0

1753

5338

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

2040.1

323.0

1192

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

323.0

4001

N05AH04

ATC

quetiapine; oral

3.8

323.0

3537

11416

G20

ICD-10 Finland

Parkinson disease

969.5

323.0

4707

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

323.0

564

N05BA04

ATC

oxazepam; oral

2.3

323.0

4275

22608

193

Kela drug reimbursment

Rasagiline

+∞

323.0

709

G24.9

ICD-10 Finland

Dystonia, unspecified

448.5

323.0

480

G25.0

ICD-10 Finland

Essential tremor

75.9

323.0

2727

440

R25.1

ICD-10 Finland

Tremor, unspecified

22.1

323.0

1947

1010

N03AG01

ATC

valproic acid; systemic, rectal

4.0

297.2

1296

3462

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

598.0

297.2

294

G24.5

ICD-10 Finland

Blepharospasm

429.0

296.0

296

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.2

288.6

1701

5782

R53

ICD-10 Finland

Malaise and fatigue

2.2

287.7

3573

18601

N06AB04

ATC

citalopram; systemic

2.2

285.2

3612

18964

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

1392.0

278.7

271

N06DA03

ATC

rivastigmine; oral, transdermal

4.4

260.1

1006

2391

N03AX16

ATC

pregabalin; oral

2.1

252.0

3839

21622

AA1AD

NOMESCO Finland

CT of head and brain

2.0

247.2

4076

23661

N06AX16

ATC

venlafaxine; oral

2.5

232.4

2109

9282

3AX01

NOMESCO Finland

41.1

225.7

286

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

2112.9

225.3

218

N05AA02

ATC

levomepromazine; systemic

4.2

222.8

923

2334

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

68.7

222.0

257

N06AX21

ATC

duloxetine; oral

2.6

214.6

1788

7484

N05AX08

ATC

risperidone; systemic

2.8

213.4

1498

5663

N05BA01

ATC

diazepam; systemic, rectal

2.3

211.9

2327

11231

N06AB10

ATC

escitalopram; oral

2.1

209.8

2800

14752

G25.3

ICD-10 Finland

Myoclonus

266.9

205.5

210

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

205.2

1209

4061

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

200.5

1791

7772

N05AX12

ATC

aripiprazole; systemic

5.1

199.7

666

1348

G25.1

ICD-10 Finland

Drug-induced tremor

118.3

193.7

210

G04BD12

ATC

mirabegron; oral

2.3

187.7

1882

8649

L28

ICPC

Limited function/disability (L)

2.0

187.0

2697

14589

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

183.3

4449

28938

N05AN01

ATC

lithium; oral

5.7

179.7

546

990

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

37.8

167.7

216

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

165.4

2193

11393

N05AH02

ATC

clozapine; systemic

7.1

165.1

423

612

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

164.7

1247

4898

N05AF03

ATC

chlorprothixene; systemic

4.8

164.0

577

1235

N03AX09

ATC

lamotrigine; oral

3.7

163.2

765

2145

A28

ICPC

Limited function/disability NOS

2.0

162.6

2594

14502

M79.6

ICD-10 Finland

Pain in limb

1.7

161.9

5017

34783

N05CF01

ATC

zopiclone; oral

1.7

160.0

4886

33707

N04BB01

ATC

amantadine; oral

6.4

159.8

441

707

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

+∞

158.6

152

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

157.6

1261

5108

A06AD11

ATC

lactulose; oral

2.0

157.4

2474

13732

N05BA06

ATC

lorazepam; systemic, sublingual

3.0

157.3

996

3491

M54.5

ICD-10 Finland

Low back pain

1.7

156.3

4475

30259

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.6

153.2

467

849

N03AA03

ATC

primidone; oral

51.7

148.0

179

R42

ICD-10 Finland

Dizziness and giddiness

1.8

147.9

3382

21303

N05CD07

ATC

temazepam; oral

2.0

147.7

2159

11620

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

+∞

145.0

139

N02BE01

ATC

paracetamol; systemic, rectal

1.7

143.8

12190

108304

G21.8

ICD-10 Finland

Other secondary parkinsonism

472.3

141.5

141

ZX114

NOMESCO Finland

Intramuscular

6.3

141.4

396

647

N05AB03

ATC

perphenazine; systemic, rectal

3.6

141.2

673

1910

SPAT1229

SPAT

Assessment of need for aid

2.3

138.8

1429

6589

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

462.1

138.4

138

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

135.7

4353

30103

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

132.0

2652

15942

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

130.7

1459

6979

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.6

128.1

473

1062

XA800

NOMESCO Finland

Neuropsychological investigation

3.3

126.1

679

2117

G47.3

ICD-10 Finland

Sleep apnoea

1.7

123.2

2854

17897

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.6

121.9

991

4029

A04

ICPC

Weakness/tiredness general

1.9

121.2

1930

10665

N06AB06

ATC

sertraline; oral

2.1

121.1

1477

7330

SPAT1216

SPAT

Assessment of functional ability

1.8

120.9

2460

14800

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

120.8

3559

23893

N06AB03

ATC

fluoxetine; oral

2.0

120.8

1784

9579

L03

ICPC

Low back symptom/complaint

1.7

119.9

3258

21383

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.2

118.1

382

744

I95.1

ICD-10 Finland

Orthostatic hypotension

3.1

117.9

693

2299

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

+∞

116.8

112

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.8

116.2

527

1432

F51.0

ICD-10 Finland

Nonorganic insomnia

2.0

116.0

1667

8843

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.3

115.4

451

1071

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

115.2

1573

8176

P72

ICPC

Schizophrenia

5.5

114.0

353

654

N06AA09

ATC

amitriptyline; systemic

2.0

113.5

1573

8223

SPAT1240

SPAT

Therapeutic discussion

2.2

112.9

1310

6354

N29

ICPC

Neurological sympt/complt other

4.4

112.9

427

982

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

111.8

1154

5301

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.1

111.4

367

730

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

110.9

2436

14966

L17

ICPC

Foot/toe symptom/complaint

1.6

108.3

3480

23783

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

108.0

646

2169

N05AC02

ATC

thioridazine; oral

4.5

107.9

401

906

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

107.2

874

3553

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

106.8

2321

14192

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

106.7

4590

33651

N06AX03

ATC

mianserin; oral

2.6

105.8

822

3250

N05BA12

ATC

alprazolam; oral

2.0

105.6

1487

7809

H02AA02

ATC

fludrocortisone; oral

8.1

105.4

245

306

G24.0

ICD-10 Finland

Drug-induced dystonia

+∞

105.3

101

N05AA01

ATC

chlorpromazine; systemic, rectal

5.9

105.2

309

537

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

103.8

1282

6376

M03BX01

ATC

baclofen; systemic

4.8

103.5

361

764

N04BC02

ATC

pergolide; oral

181.3

103.4

108

N04

ICPC

Restless legs

11.6

102.8

196

171

N05AD01

ATC

haloperidol; systemic

3.2

102.8

579

1863

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

102.4

3487

24128

M48.0

ICD-10 Finland

Spinal stenosis

1.8

102.3

1897

11006

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

101.7

1085

5055

N06AX12

ATC

bupropion; oral

2.7

101.6

724

2721

SPAT1234

SPAT

Support of social functional capacity

2.5

101.4

882

3712

G24

ICD-10 Finland

Dystonia

122.0

101.1

109

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.0

99.2

625

2173

R06.0

ICD-10 Finland

Dyspnoea

1.6

97.1

3497

24470

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.7

96.1

721

2792

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

95.9

673

2502

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

95.7

974

4431

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

95.7

760

3041

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

95.1

3770

26961

P29

ICPC

Psychological sympt/compl other

2.7

94.6

689

2619

R13

ICD-10 Finland

Dysphagia

2.2

93.7

1004

4681

N03AX11

ATC

topiramate; oral

4.1

93.3

385

962

TAB00

NOMESCO Finland

Lumbar puncture

2.8

90.6

641

2395

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.8

90.5

316

670

XF606

NOMESCO Finland

Ortostatic test

7.6

90.2

219

293

P01

ICPC

Feeling anxious/nervous/tense

2.1

89.3

1047

5080

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.6

89.1

269

484

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.4

88.9

243

385

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

88.9

2032

12549

A02BC02

ATC

pantoprazole; systemic

1.4

88.8

8849

75801

N05AF05

ATC

zuclopenthixol; systemic

6.5

87.8

238

373

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

13.0

87.5

158

123

P99

ICPC

Psychological disorders other

3.8

87.5

387

1029

N30.0

ICD-10 Finland

Acute cystitis

1.7

87.2

1922

11736

R51.80

ICD-10 Finland

Headache

1.8

87.2

1787

10669

R35

ICD-10 Finland

Polyuria

2.2

86.7

993

4766

N06AX26

ATC

vortioxetine; oral

2.5

86.2

696

2810

R1250

NOMESCO Finland

Evaluation of functional capability

3.8

86.0

388

1049

N99

ICPC

Neurological disease other

5.3

85.9

273

522

N28

ICPC

Limited function/disability (N)

4.3

85.5

332

784

N05CF02

ATC

zolpidem; oral

1.7

85.3

2254

14494

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

85.0

2060

12929

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

290.1

84.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

84.1

3982

29451

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

84.0

2840

19460

A02BC05

ATC

esomeprazole; systemic

1.4

83.4

5338

41917

K02.1

ICD-10 Finland

Caries of dentine

1.4

83.0

6785

55731

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

83.0

475

1545

L01

ICPC

Neck symptom/complaint

1.7

82.5

1768

10686

N08

ICPC

Abnormal involuntary movements

19.5

82.1

126

P20

ICPC

Memory disturbance

1.7

81.7

1875

11570

G44.2

ICD-10 Finland

Tension-type headache

1.8

80.8

1644

9774

SPAT1301

SPAT

No procedures

1.5

80.8

4346

32939

P76

ICPC

Depressive disorder

2.4

79.7

719

3078

N04BC06

ATC

cabergoline; oral (dopamine agonists)

11.6

79.6

151

131

R60.0

ICD-10 Finland

Localized oedema

1.8

79.5

1583

9343

G51.3

ICD-10 Finland

Clonic hemifacial spasm

17.6

79.2

126

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

78.3

1416

8098

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.9

78.3

497

1732

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

77.9

2052

13151

SPAT1254

SPAT

Administration of medicine

1.6

77.6

2089

13465

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

77.1

920

4489

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.3

76.5

243

465

M03BX02

ATC

tizanidine; oral

1.4

76.1

7628

64513

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

76.0

8617

74419

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.6

75.6

571

2217

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

74.6

1302

7349

G24.4

ICD-10 Finland

Idiopathic orofacial dystonia

+∞

73.0

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

72.9

814

3854

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

72.2

2726

19076

N02AX02

ATC

tramadol; systemic, rectal

1.4

71.9

5615

45331

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

71.5

6377

52648

A02BC01

ATC

omeprazole; systemic

1.4

71.3

3763

28257

P03

ICPC

Feeling depressed

2.0

69.6

934

4780

N03AF01

ATC

carbamazepine; oral, rectal

2.2

69.2

764

3597

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.7

68.8

499

1891

WX110

NOMESCO Finland

Local anesthesy

1.4

68.5

8595

74796

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

9.9

68.5

141

144

K59.0

ICD-10 Finland

Constipation

2.1

68.5

823

4025

S06.0

ICD-10 Finland

Concussion

1.8

68.3

1318

7683

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.1

67.6

223

446

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

66.7

5462

44269

J01DB01

ATC

cefalexin; oral

1.4

66.7

10856

98418

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

66.5

1760

11255

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.3

66.4

255

597

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.1

66.1

782

3797

A02BC03

ATC

lansoprazole; oral

1.4

65.7

3892

29782

SPAT1053

SPAT

Memory test

1.5

65.4

2247

15340

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

41.2

65.4

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

65.3

7613

65232

N05BE01

ATC

buspirone; oral

2.9

65.3

428

1525

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.2

65.2

181

294

R4130

NOMESCO Finland

Speech therapy

3.1

65.1

369

1193

M03AX01

ATC

botulinum toxin; parenteral

5.9

64.5

186

317

188

Kela drug reimbursment

Psychosis requiring demanding treatment

5.4

64.5

201

377

R52.9

ICD-10 Finland

Pain, unspecified

1.9

64.4

1101

6159

N06AB05

ATC

paroxetine; oral

2.1

64.1

774

3789

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

4.0

63.7

268

683

G24.1

ICD-10 Finland

Idiopathic familial dystonia

+∞

63.6

D21

ICPC

Swallowing problem

4.0

63.5

262

656

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.9

63.5

417

1487

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.7

63.3

451

1691

N06AG02

ATC

moclobemide; oral

2.3

63.2

642

2909

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

63.2

4014

31062

M79.1

ICD-10 Finland

Myalgia

1.7

63.1

1534

9570

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.5

62.7

233

528

R55

ICD-10 Finland

Syncope and collapse

1.7

62.6

1515

9438

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

62.3

4938

39675

A01

ICPC

Pain general/multiple sites

1.9

62.0

1034

5728

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.4

61.9

310

914

SPAT1263

SPAT

Sampling

1.4

61.7

5496

44986

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

61.3

1570

9934

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

7.5

61.2

148

198

U04

ICPC

Incontinence urine

2.2

60.9

689

3279

N19

ICPC

Speech disorder

4.4

60.6

227

519

3338X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Fragments of torsion dystonia

+∞

60.4

XKD00

NOMESCO Finland

Uroflowmetry

1.5

60.2

2214

15326

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

60.1

5680

46864

M25.5

ICD-10 Finland

Pain in joint

1.4

60.0

3336

25145

SPAT1260

SPAT

Consultation of another employee

1.5

59.9

2326

16297

P06

ICPC

Sleep disturbance

1.8

59.8

1137

6583

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

59.6

6590

55671

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

59.2

1082

6179

R25.2

ICD-10 Finland

Cramp and spasm

3.1

59.0

345

1137

R03AC02

ATC

salbutamol; inhalant

1.3

58.7

6502

54893

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

58.5

368

1276

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.0

58.2

821

4278

N06AA12

ATC

doxepin; systemic

2.0

58.1

763

3867

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.7

57.8

265

728

G04BD08

ATC

solifenacin; oral

1.9

57.7

976

5432

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.9

57.1

193

397

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.6

56.9

266

743

29580

ICD-8 Finland

Schizophrenia, Other

7.3

56.8

140

193

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

56.8

3307

25093

N06AX05

ATC

trazodone; oral

2.9

56.8

353

1216

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

560.2

56.6

N06AX22

ATC

agomelatine; oral

3.6

56.6

264

736

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.3

56.5

541

2381

N06AA06

ATC

trimipramine; systemic

2.8

56.2

380

1381

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.2

56.2

309

978

UKC02

NOMESCO Finland

Cystoscopy

1.5

56.2

2238

15745

J01EA01

ATC

trimethoprim; systemic

1.4

55.7

3275

24879

C03CA01

ATC

furosemide; systemic

1.4

54.7

4123

32674

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.3

54.7

284

862

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

54.5

5782

48307

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

54.3

972

5512

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

12.1

54.1

100

M79.7

ICD-10 Finland

Fibromyalgia

2.6

54.1

413

1611

F34.1

ICD-10 Finland

Dysthymia

2.5

54.0

433

1737

R47.1

ICD-10 Finland

Dysarthria and anarthria

4.7

53.9

189

405

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

53.8

933

5234

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.2

53.8

212

510

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

53.6

5730

47887

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

53.5

855

4663

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

53.2

658

3250

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

53.1

294

935

AA400

NOMESCO Finland

Electroconvulsive therapy

5.7

53.0

158

282

29599

ICD-8 Finland

Schizophrenia, Unspecified type

6.9

53.0

135

196

N04AA01

ATC

trihexyphenidyl; oral

41.4

52.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

52.8

4420

35573

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

52.7

2203

15634

G04CA02

ATC

tamsulosin; oral

1.4

52.2

3064

23227

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

52.1

1852

12684

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.3

52.0

165

317

N17

ICPC

Vertigo/dizziness

1.6

51.9

1443

9308

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

51.7

6606

56536

SPAT1243

SPAT

Psychiatric/psychological examination

3.1

51.3

301

995

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

51.2

1672

11221

W19

ICD-10 Finland

Unspecified fall

1.7

51.1

1179

7226

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.5

50.9

136

211

F32.1

ICD-10 Finland

Moderate depressive episode

2.2

50.7

545

2533

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

50.4

1754

11946

M54

ICD-10 Finland

Dorsalgia

1.6

50.3

1284

8089

H03AA01

ATC

levothyroxine sodium; systemic

1.4

50.3

2909

21968

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

2.1

50.2

629

3123

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.4

50.2

450

1917

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

49.7

1225

7650

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.4

49.4

249

739

Z71.8

ICD-10 Finland

Other specified counselling

1.4

49.4

2681

20007

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

49.1

546

2576

N05AL01

ATC

sulpiride; systemic

3.3

49.0

254

771

F31

ICD-10 Finland

Bipolar affective disorder

4.6

48.7

176

389

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

48.7

1924

13472

L02

ICPC

Back symptom/complaint

1.7

48.7

1032

6165

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.9

48.7

304

1049

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

48.6

4460

36288

S01.0

ICD-10 Finland

Open wound of scalp

1.8

48.4

952

5557

F20.5

ICD-10 Finland

Residual schizophrenia

6.3

48.4

132

211

R52.2

ICD-10 Finland

Other chronic pain

2.4

48.1

443

1914

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

48.0

1692

11545

WX290

NOMESCO Finland

Other blockade of nerve

1.3

48.0

4644

38059

EBA00

NOMESCO Finland

Extraction of tooth

1.3

48.0

3807

30277

G24.2

ICD-10 Finland

Idiopathic nonfamilial dystonia

+∞

47.9

S18

ICPC

Laceration/cut

1.3

47.8

5375

45003

F61.0

ICD-10 Finland

Mixed personality disorders

3.7

47.8

216

588

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

47.4

567

2761

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

47.3

753

4094

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.3

47.3

253

786

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

5.2

46.5

148

286

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

46.5

4659

38341

P74

ICPC

Anxiety disorder/anxiety state

2.6

46.3

362

1433

R02

ICPC

Shortness of breath/dyspnoea

1.5

46.2

1512

10135

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

46.2

3180

24688

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

46.1

454

2026

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

46.1

4297

34975

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.7

45.6

204

551

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

45.6

1224

7812

R06.5

ICD-10 Finland

Mouth breathing

1.7

45.4

991

5973

G90.3

ICD-10 Finland

Multi-system degeneration

43.2

45.3

A02BA02

ATC

ranitidine; systemic

1.4

45.2

2601

19574

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

45.0

4930

41023

F20

ICD-10 Finland

Schizophrenia

6.0

44.9

127

213

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

44.9

593

3008

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

44.8

2244

16458

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

44.4

339

1325

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.3

44.2

436

1948

Z01.2

ICD-10 Finland

Dental examination

1.3

44.1

4587

37867

R32

ICD-10 Finland

Unspecified urinary incontinence

2.4

44.0

392

1665

R07.3

ICD-10 Finland

Other chest pain

1.6

43.7

1156

7344

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

43.4

2967

22975

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

43.4

2137

15613

WZA90

NOMESCO Finland

Other doctors statement

1.4

43.3

2595

19648

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

43.0

1436

9662

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

42.8

1151

7346

C07AB07

ATC

bisoprolol; oral

1.3

42.7

6373

55124

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.9

42.6

181

468

R11

ICD-10 Finland

Nausea and vomiting

1.7

42.5

970

5916

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

6.5

42.3

113

176

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

42.1

1983

14357

N03AF02

ATC

oxcarbazepine; oral

2.3

42.0

393

1709

U02

ICPC

Urinary frequency/urgency

1.5

42.0

1578

10901

R49.02

ICD-10 Finland

Spasmodic dysphonia

11.7

41.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

41.5

2745

21113

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

41.5

489

2368

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

41.4

2082

15256

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

41.4

4764

39783

F05.9

ICD-10 Finland

Delirium, unspecified

2.7

41.4

296

1115

KMAK

NOMESCO Finland

1.3

41.4

5905

50716

J01CA08

ATC

pivmecillinam; oral

1.3

41.4

4639

38605

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

41.1

611

3241

R33

ICD-10 Finland

Retention of urine

1.6

41.0

1035

6492

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

40.9

1150

7417

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.0

40.8

134

269

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

+∞

40.6

3331A

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Essential and other specified forms of tremor

+∞

40.6

A29

ICPC

General symptom/complaint other

1.5

40.6

1367

9210

XA402

NOMESCO Finland

ENMG

2.5

40.4

336

1378

L12

ICPC

Hand/finger symptom/complaint

1.5

40.3

1609

11256

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

40.3

756

4342

G04BD07

ATC

tolterodine; oral

1.8

40.2

710

4000

N05AF01

ATC

flupentixol; systemic

2.9

40.0

249

859

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.7

40.0

181

494

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

40.0

452

2148

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

6.4

40.0

108

171

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

40.0

419

1925

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

39.9

226

733

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

39.9

258

912

AA5QN

NOMESCO Finland

75.3

39.9

N05AE04

ATC

ziprasidone; systemic

6.4

39.7

107

169

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.8

39.7

172

453

R05

ICD-10 Finland

Cough

1.4

39.7

2302

17299

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

5.9

39.6

114

196

F40.1

ICD-10 Finland

Social phobias

3.2

39.5

218

694

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

39.4

483

2378

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

39.3

700

3955

G02CB01

ATC

bromocriptine; systemic

3.3

38.8

206

638

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.8

38.7

170

453

R41.0

ICD-10 Finland

Disorientation, unspecified

2.1

38.7

433

2050

Z00.0

ICD-10 Finland

General medical examination

1.4

38.4

2183

16336

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.7

38.3

273

1028

R4110

NOMESCO Finland

Physiotherapy

1.3

38.2

3227

25743

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

21.6

38.2

UJF32

NOMESCO Finland

Coloscopy

1.3

38.2

3254

25990

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.0

38.1

226

756

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.8

38.0

110

191

F20.0

ICD-10 Finland

Paranoid schizophrenia

5.2

37.7

119

229

D12

ICPC

Constipation

2.1

37.5

448

2181

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

37.5

715

4130

P98

ICPC

Psychosis NOS/other

6.1

37.5

104

171

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

37.5

1429

9888

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.1

37.5

152

378

J02AC01

ATC

fluconazole; systemic

1.3

37.4

4429

36999

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

37.4

845

5134

IGY02

SPAT

6.1

37.3

104

172

M01AC06

ATC

meloxicam; systemic, rectal

1.3

37.3

4424

36962

F22.0

ICD-10 Finland

Delusional disorder

3.0

37.3

223

752

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

37.2

1229

8240

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

16.9

37.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

37.0

1352

9268

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

37.0

1121

7364

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

36.9

1654

11838

L29

ICPC

Musculoskeletal sympt/complt other

1.7

36.8

894

5543

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.5

36.8

135

305

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

36.7

803

4833

R03DC03

ATC

montelukast; oral

1.4

36.7

1726

12466

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

25.6

36.6

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

36.2

619

3448

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.3

36.1

138

325

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

8.5

35.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

35.8

1432

10006

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.5

35.7

288

1162

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

35.7

2056

15408

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

35.6

625

3511

U07

ICPC

Urine symptom/complaint other

1.7

35.5

716

4210

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

35.4

4963

42270

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.8

35.3

232

831

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

35.1

2766

21798

M54.1

ICD-10 Finland

Radiculopathy

2.0

35.0

458

2316

J01MA02

ATC

ciprofloxacin; systemic

1.3

35.0

4903

41741

F32

ICD-10 Finland

Depressive episode

1.9

34.9

523

2784

R50.9

ICD-10 Finland

Fever, unspecified

1.4

34.9

1594

11441

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

34.7

1728

12607

29530

ICD-8 Finland

Schizophrenia, Paranoid type

6.5

34.6

140

3339X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders

+∞

34.4

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.8

34.3

231

840

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

34.3

619

3510

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

34.2

609

3441

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

34.1

351

1602

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

7.2

34.0

118

L86

ICPC

Back syndrome with radiating pain

1.8

34.0

649

3749

G25.5

ICD-10 Finland

Other chorea

338.0

33.9

SPAT1310

SPAT

Counselling related to known health issue

1.3

33.7

3867

32079

R01AD09

ATC

mometasone; nasal

1.3

33.7

5000

42805

M54.2

ICD-10 Finland

Cervicalgia

1.7

33.6

768

4680

R27.0

ICD-10 Finland

Ataxia, unspecified

5.9

33.5

161

M01AE02

ATC

naproxen; oral, rectal

1.2

33.5

6751

59823

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

8.0

33.5

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

33.5

699

4146

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.8

33.4

220

789

N05AD03

ATC

melperone; systemic

2.9

33.4

211

738

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

33.3

2056

15566

G21.2

ICD-10 Finland

Secondary parkinsonism due to other external agents

+∞

33.3

L14

ICPC

Leg/thigh symptom/complaint

1.6

33.2

879

5573

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

33.2

1185

8078

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

7.1

33.1

116

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.9

33.0

204

704

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

33.0

2517

19712

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

327.8

32.9

K30

ICD-10 Finland

Functional dyspepsia

1.5

32.8

1172

7985

L15

ICPC

Knee symptom/complaint

1.3

32.6

2421

18879

M01AB05

ATC

diclofenac; systemic, rectal

1.2

32.5

8219

74549

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.6

32.5

153

434

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

32.4

257

1027

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.6

32.3

246

962

130

Kela drug reimbursment

Malignant tumour

0.6

32.3

417

7192

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

32.3

2818

22501

A03FA02

ATC

cisapride; oral, rectal

1.6

32.2

1000

6599

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

32.2

2746

21855

N01

ICPC

Headache

1.6

32.2

946

6160

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

32.1

583

3313

E0000UV

ATC

1.3

32.0

4610

39264

I95.9

ICD-10 Finland

Hypotension, unspecified

2.9

31.8

202

709

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

31.8

260

1057

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

31.8

491

2643

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

5.8

31.7

157

F20.10

ICD-10 Finland

Raise schizophrenia continuously

6.3

31.7

138

R25.0

ICD-10 Finland

Abnormal head movements

22.0

31.7

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

31.7

498

2699

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

31.5

638

3753

D82

ICPC

Teeth/gum disease

1.3

31.3

3621

30003

G23.2

ICD-10 Finland

Multiple system atrophy, parkinsonian type [MSA-P]

+∞

31.2

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

31.2

2692

21440

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.1

31.2

175

566

J01CA04

ATC

amoxicillin; systemic

1.2

31.2

10158

94488

D11

ICPC

Diarrhoea

1.5

30.8

1092

7430

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

7.8

30.7

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.7

30.6

135

363

R4120

NOMESCO Finland

Occupational therapy

1.7

30.6

720

4424

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

30.5

4161

35159

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.4

30.4

261

1091

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.1

30.4

169

544

N06AA04

ATC

clomipramine; systemic

2.6

30.3

226

874

XKC03

NOMESCO Finland

Water cystometry

2.0

30.2

393

1983

N04BX04

ATC

opicapone; oral

+∞

30.2

SPAT1262

SPAT

Handing over of treatment supplies

1.3

30.0

2237

17427

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

30.0

379

1891

2957A

ICD-9 Finland

Schizophrenic psychoses, Schizo-affective type

6.4

29.9

123

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

6.5

29.8

120

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.1

29.7

166

537

-1

NOMESCO Finland

1.3

29.6

3516

29198

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

29.5

2034

15655

SPAT1360

SPAT

Extensive global examination

1.6

29.5

914

6028

H81

ICPC

Excessive ear wax

1.4

29.5

1992

15285

K08.3

ICD-10 Finland

Retained dental root

1.6

29.3

795

5070

SPAT1312

SPAT

General health counselling

1.3

29.3

3722

31150

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

29.3

1133

7850

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

29.3

619

3690

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

29.2

858

5585

34200

ICD-8 Finland

Paralysis agitans, Parkinsonismus

+∞

29.2

N04BC07

ATC

apomorphine; parenteral

+∞

29.2

M01AH05

ATC

etoricoxib; oral

1.2

29.1

6855

61390

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

28.9

1037

7071

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.8

28.7

189

680

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

28.7

2998

24473

R51

ICD-10 Finland

Headache

1.8

28.6

520

2957

R05

ICPC

Cough

1.3

28.5

2488

19819

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

28.5

674

4149

Z29

ICPC

Social problem NOS

2.5

28.5

223

889

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

4.9

28.5

192

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

28.4

2161

16873

N06AB08

ATC

fluvoxamine; oral

2.1

28.4

327

1569

N04BC01

ATC

bromocriptine; oral

26.0

28.3

SPAT1167

SPAT

Insertion of urinary catheter

1.9

28.2

437

2355

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.3

28.1

165

N07BB01

ATC

disulfiram; oral

1.9

28.0

432

2326

N06BA04

ATC

methylphenidate; oral

3.0

27.9

165

555

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

27.8

389

2017

J45

ICD-10 Finland

Asthma

1.5

27.8

1039

7144

G04BD09

ATC

trospium; oral

2.0

27.8

350

1744

SPAT1252

SPAT

Overall medication plan or its review

1.5

27.7

874

5785

H50.52

ICD-10 Finland

Exophoria

3.5

27.7

134

390

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

27.6

758

4850

L13

ICPC

Hip symptom/complaint

1.3

27.6

1871

14352

L08

ICPC

Shoulder symptom/complaint

1.3

27.5

2163

16966

SPAT1153

SPAT

Removal of sutures

1.2

27.5

3957

33551

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

27.5

3485

29118

G72.8

ICD-10 Finland

Other specified myopathies

2.6

27.2

208

818

SPAT1101

SPAT

Orthostatic test

1.7

27.2

577

3444

C01CA01

ATC

etilefrine; systemic

3.5

27.1

128

365

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

5.3

27.1

156

F0230, G20

ICD-10 Finland

+∞

27.1

F0232, G20

ICD-10 Finland

+∞

27.1

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

27.1

462

2574

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.4

27.0

131

382

P28

ICPC

Limited function/disability (P)

3.7

27.0

119

321

A11

ICPC

Chest pain NOS

1.5

27.0

869

5780

L19

ICPC

Muscle symptom/complaint NOS

2.2

27.0

292

1364

A06AC51

ATC

ispaghula, combinations; systemic

1.7

26.9

569

3392

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

4.5

26.9

213

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

6.8

26.9

100

L16

ICPC

Ankle symptom/complaint

1.5

26.9

1071

7461

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

26.8

1085

7584

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

26.8

417

2250

K07

ICPC

Swollen ankles/oedema

1.7

26.8

543

3196

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

7.4

26.7

J01AA02

ATC

doxycycline; systemic

1.2

26.6

10074

94185

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

26.6

400

2132

WX002

NOMESCO Finland

Sedation and analgesia

1.3

26.6

2357

18794

SPAT1244

SPAT

Occupational therapy

3.0

26.6

159

537

R00.2

ICD-10 Finland

Palpitations

1.6

26.5

735

4717

U05

ICPC

Urination problems other

1.7

26.5

556

3306

L84

ICPC

Back syndrome without radiat pain

1.8

26.5

468

2637

D01

ICPC

Abdominal pain/cramps general

1.5

26.4

1084

7598

A01AB09

ATC

miconazole; local oral

1.5

26.4

1045

7270

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

26.3

917

6210

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

26.3

448

2498

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

1.8

26.1

458

2577

H02AB02

ATC

dexamethasone; systemic

0.6

26.1

567

8676

H53.2

ICD-10 Finland

Diplopia

2.0

26.0

358

1846

A05

ICPC

Feeling ill

1.7

26.0

536

3169

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

25.9

491

2830

N05AE05

ATC

lurasidone; oral

9.2

25.8

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

25.8

1134

8056

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.1

25.7

300

1448

R30.1

ICD-10 Finland

Vesical tenesmus

2.4

25.7

230

984

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

25.7

3528

29713

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

25.7

1281

9322

M54.3

ICD-10 Finland

Sciatica

1.6

25.7

645

4035

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

2.5

25.6

201

802

A99

ICPC

Disease/condition unspecnature/site

1.5

25.6

903

6127

SPAT1235

SPAT

Mental health, emotional support

4.0

25.6

103

257

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

25.5

774

5076

G04BD11

ATC

fesoterodine; oral

1.9

25.5

391

2100

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

25.5

1020

7111

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

5.1

25.4

160

L84

ICD-10 Finland

Corns and callosities

1.9

25.2

404

2203

R01AD08

ATC

fluticasone; nasal

1.3

25.2

3037

25174

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.8

25.2

109

290

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

25.1

344

1773

ZXA10

NOMESCO Finland

Bilateral

1.3

25.0

2245

17917

G25.6

ICD-10 Finland

Drug-induced tics and other tics of organic origin

+∞

25.0

SPAT1050

SPAT

Extensive neurological examination

2.1

24.9

281

1340

SPAT1211

SPAT

Application of soft bandage

1.5

24.9

1040

7315

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

24.8

839

5639

L60.0

ICD-10 Finland

Ingrowing nail

1.8

24.8

463

2659

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.5

24.8

192

761

S70.0

ICD-10 Finland

Contusion of hip

1.8

24.8

424

2367

F20.8

ICD-10 Finland

Other schizophrenia

5.9

24.7

120

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

24.6

658

4184

R23

ICPC

Voice symptom/complaint

2.3

24.5

230

1007

R4110

SPAT

1.9

24.4

341

1769

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

24.4

493

2897

M01AH02

ATC

rofecoxib; oral

1.3

24.4

1604

12231

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.4

24.4

203

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.0

24.3

319

1620

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

24.3

5167

45509

R03BA02

ATC

budesonide; inhalant

1.3

24.2

1903

14899

S29

ICPC

Skin symptom/complaint other

1.3

24.2

1910

14962

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

24.1

779

5184

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

24.1

2303

18526

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.1

24.1

269

1278

N06AA10

ATC

nortriptyline; systemic

2.2

24.0

243

1104

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.9

24.0

352

1863

E86

ICD-10 Finland

Volume depletion

2.0

23.9

303

1517

U01

ICPC

Dysuria/painful urination

1.5

23.9

778

5187

G04CA01

ATC

alfuzosin; oral

1.4

23.9

1349

10030

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

23.9

2993

24909

R06AE07

ATC

cetirizine; oral

1.2

23.8

4868

42682

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

23.8

1520

11531

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.0

23.8

143

486

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

23.7

963

6728

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

23.7

1498

11347

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

23.6

1830

14298

D07AA02

ATC

hydrocortisone; topical

1.4

23.5

1402

10517

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

10.2

23.4

SPAT1104

SPAT

Monitoring of emergency patient

1.5

23.4

778

5211

N02AA05

ATC

oxycodone; systemic

1.3

23.3

1768

13765

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

23.3

3833

32857

P73

ICPC

Affective psychosis

5.1

23.3

146

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

23.3

3182

26730

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

5.8

23.2

114

P01AB01

ATC

metronidazole; oral, rectal

1.2

23.2

4481

39043

R44.1

ICD-10 Finland

Visual hallucinations

4.4

23.2

195

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

7.2

23.1

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

23.1

2090

16686

A08

ICPC

Swelling

1.7

23.1

494

2956

K07.60

ICD-10 Finland

Snapping jaw

1.8

23.1

434

2497

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

23.0

2638

21702

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

23.0

534

3267

Z50.1

ICD-10 Finland

Other physical therapy

1.6

23.0

631

4040

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.7

22.9

156

576

R44.3

ICD-10 Finland

Hallucinations, unspecified

4.7

22.9

170

EBA30

NOMESCO Finland

Excision of root of tooth

1.6

22.9

605

3832

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

22.9

2548

20883

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

22.9

592

3730

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

22.9

3092

25927

M02AA07

ATC

piroxicam; topical

1.2

22.9

4507

39331

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.2

22.8

123

390

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

22.8

1279

9493

SPAT1281

SPAT

Other administrative function

1.5

22.8

872

6022

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.5

22.7

913

6367

R5110

SPAT

1.9

22.7

317

1649

29560

ICD-8 Finland

Residual schizophrenia

12.1

22.7

3AX0X

NOMESCO Finland

83.5

22.6

G43.3

ICD-10 Finland

Complicated migraine

2.9

22.6

142

497

N05BA02

ATC

chlordiazepoxide; systemic

2.0

22.6

289

1453

S22

ICPC

Nail symptom/complaint

1.6

22.5

640

4131

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

22.4

424

2445

K03.66

ICD-10 Finland

Tooth plaque

1.6

22.3

652

4238

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

22.3

344

1854

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.6

22.3

165

638

XG466

NOMESCO Finland

Sleep oxymetry

1.8

22.2

365

2008

F20.34

ICD-10 Finland

Undifferentiated schizophrenia with partial recurrence

5.9

22.2

105

Z50.5

ICD-10 Finland

Speech therapy

2.7

22.2

155

582

R03BA05

ATC

fluticasone; inhalant

1.3

22.2

1939

15396

S22.3

ICD-10 Finland

Fracture of rib

1.5

22.2

711

4723

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

22.2

1478

11283

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

22.1

876

6092

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.5

22.1

177

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.2

22.1

117

367

N30

ICD-10 Finland

Cystitis

1.5

22.1

750

5049

N06AX17

ATC

milnacipran; oral

2.8

22.0

140

496

F20.1

ICD-10 Finland

Hebephrenic schizophrenia

9.0

21.9

H13

ICPC

Plugged feeling ear

1.3

21.8

2118

17056

F32.8

ICD-10 Finland

Other depressive episodes

2.7

21.7

147

541

Z75.5

ICD-10 Finland

Holiday relief care

2.9

21.7

131

448

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.0

21.6

223

J01DA01

ATC

[U] cefalexin; systemic

1.2

21.6

7725

71053

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

21.6

11414

108800

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

6.4

21.6

IHZ05

SPAT

2.7

21.6

151

568

S20.2

ICD-10 Finland

Contusion of thorax

1.7

21.6

503

3087

C07AB02

ATC

metoprolol; systemic

1.3

21.5

2668

22137

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

21.5

960

6836

29999

ICD-8 Finland

Unspecified psychosis

4.4

21.4

178

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

5.7

21.4

110

M01AX17

ATC

nimesulide; oral

1.2

21.4

2941

24682

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.2

21.4

3721

32027

R41.3

ICD-10 Finland

Other amnesia

1.8

21.4

358

1988

A07AA02

ATC

nystatin; oral

1.5

21.3

727

4899

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.8

21.2

136

485

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

21.2

231

1088

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.2

21.0

213

971

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.1

21.0

118

386

N39.3

ICD-10 Finland

Stress incontinence

1.5

21.0

755

5143

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

10.3

21.0

F44.4

ICD-10 Finland

Dissociative motor disorders

15.5

21.0

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

20.9

741

5032

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.5

20.9

152

3086

R03BA08

ATC

ciclesonide; inhalant

1.5

20.9

833

5801

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

20.9

241

1164

N05CD02

ATC

nitrazepam; oral

2.1

20.8

241

1166

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.9

20.8

127

439

F41.00

ICD-10 Finland

Moderate panic disorder

2.7

20.7

142

528

SFA00

NOMESCO Finland

Small filling

1.4

20.7

1289

9727

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

20.7

987

7115

SPAT1251

SPAT

Organisation of medication

1.7

20.7

438

2615

N76.0

ICD-10 Finland

Acute vaginitis

1.7

20.7

403

2348

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.0

20.6

279

1435

R2110

NOMESCO Finland

Giving the first information

1.5

20.6

685

4591

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

20.6

343

1898

N04BX01

ATC

tolcapone; oral

210.2

20.6

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

1.9

20.6

285

1479

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

20.5

596

3866

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.3

20.5

198

883

N05AX13

ATC

paliperidone; systemic

4.8

20.3

139

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.6

20.2

252

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

20.2

722

4913

A02BC04

ATC

rabeprazole; oral

1.4

20.2

860

6070

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.5

20.1

162

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.8

20.1

224

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

20.0

390

2271

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

6.2

20.0

F03

ICD-10 Finland

Unspecified dementia

1.6

20.0

511

3212

F06.0

ICD-10 Finland

Organic hallucinosis

6.4

20.0

G47.8

ICD-10 Finland

Other sleep disorders

3.9

19.9

216

G54.0

ICD-10 Finland

Brachial plexus disorders

2.1

19.8

228

1098

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.5

19.8

161

659

3321A

ICD-9 Finland

Parkinson's disease, Secondary Parkinsonism

+∞

19.8

G21

ICD-10 Finland

Secondary parkinsonism

+∞

19.8

S04

ICPC

Lump/swelling localized

1.4

19.7

937

6751

183

Kela drug reimbursment

Lamotrigin and topiramate

3.2

19.6

105

333

K02

ICD-10 Finland

Dental caries

1.5

19.5

673

4545

E000001

ATC

1.3

19.5

2205

18074

D07AC01

ATC

betamethasone; topical

1.2

19.4

3930

34260

K04.0

ICD-10 Finland

Pulpitis

1.5

19.4

789

5519

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

19.3

2697

22644

F45.0

ICD-10 Finland

Somatization disorder

4.2

19.3

174

ZXA00

NOMESCO Finland

Right side

1.2

19.2

3267

28004

SPAT1284

SPAT

Extensive health certificate

1.9

19.1

294

1585

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.0

19.1

237

1178

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

8.0

19.1

R12

ICD-10 Finland

Heartburn

1.5

19.1

699

4781

N03AX14

ATC

levetiracetam; systemic

1.9

19.1

271

1419

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

19.1

1241

9431

R52.1

ICD-10 Finland

Chronic intractable pain

3.0

19.0

109

360

H02.3

ICD-10 Finland

Blepharochalasis

1.5

19.0

707

4854

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.8

19.0

123

443

SPAT1139

SPAT

Nutrition survey

1.7

19.0

371

2162

N05AE03

ATC

sertindole; oral

6.7

19.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

19.0

2170

17804

F02.34

ICD-10 Finland

Dementia in Parkinson's disease, other additional symptoms of mixed type

+∞

18.7

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

18.7

436

2674

SPAT1325

SPAT

Vaccination

1.2

18.7

4291

37816

R30.0

ICD-10 Finland

Dysuria

1.7

18.7

372

2184

R1260

NOMESCO Finland

Evaluation of communicative skills

2.1

18.7

205

968

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

18.6

352

2032

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

18.6

812

5756

D19

ICPC

Teeth/gum symptom/complaint

1.2

18.6

2572

21564

N07XX06

ATC

tetrabenazine; oral

190.2

18.5

SGA01

NOMESCO Finland

Tooth opening as first aid

1.3

18.5

1386

10759

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.1

18.5

172

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

18.5

856

6136

D06

ICPC

Abdominal pain localized other

1.4

18.5

795

5621

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

18.4

835

5961

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.3

18.4

1198

9100

U71

ICPC

Cystitis/urinary infection other

1.5

18.4

626

4213

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

18.4

832

5938

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

18.4

238

1204

R03BA01

ATC

beclometasone; inhalant

1.3

18.4

1528

12033

ICB03

SPAT

7.2

18.4

R05FB02

ATC

cough suppressants and expectorants

1.2

18.4

4575

40592

SPAT1058

SPAT

PEF monitoring instruction

1.4

18.3

905

6562

IGY99

SPAT

4.1

18.3

178

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.9

18.3

113

395

L99

ICPC

Musculoskeletal disease other

2.1

18.3

217

1060

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

5.7

18.3

AA1AA

NOMESCO Finland

Head X-ray examination

2.8

18.3

114

402

L05

ICPC

Flank/axilla symptom/complaint

1.5

18.2

561

3693

A46

ICD-10 Finland

Erysipelas

1.3

18.2

1584

12547

S80.0

ICD-10 Finland

Contusion of knee

1.5

18.2

612

4109

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

18.2

219

1079

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

5.4

18.2

100

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

6.2

18.1

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

18.1

233

1176

TKC22

NOMESCO Finland

Catheterisation instruction

2.0

18.0

244

1257

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.3

18.0

272

R26.0

ICD-10 Finland

Ataxic gait

5.4

18.0

101

R49.08

ICD-10 Finland

Other specified dysphonia

2.0

18.0

228

1144

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

17.9

828

5932

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.3

17.9

1201

9169

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

17.9

380

2272

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.4

17.7

150

627

F02.31

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly paranoidism

+∞

17.7

N06AX18

ATC

reboxetine; oral

2.5

17.7

137

548

SPAT1097

SPAT

Recording of ECG

1.3

17.6

1767

14258

TCE00

NOMESCO Finland

Therapeutic injection into extraocular muscle

36.7

17.6

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.6

17.5

129

501

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.2

17.5

2521

21207

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.8

17.5

327

1881

VALMI

NOMESCO Finland

1.2

17.5

2401

20092

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

17.5

2642

22339

J01FA06

ATC

roxithromycin; oral

1.2

17.4

4646

41412

H02AB06

ATC

prednisolone; systemic

1.2

17.4

5632

51005

S21

ICPC

Skin texture symptom/complaint

1.3

17.4

1336

10398

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

17.4

2358

19705

R96

ICPC

Asthma

1.4

17.4

910

6667

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

17.4

5693

51606

SBB10

NOMESCO Finland

Teeth copy

1.5

17.4

528

3469

A01AB04

ATC

amphotericin B; local oral

1.5

17.3

552

3661

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.3

17.3

1287

9971

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

17.3

1147

8737

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

17.3

1175

8981

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

17.2

752

5328

P25

ICPC

Phase of life problem adult

1.8

17.2

319

1829

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.4

17.2

151

645

R5599

NOMESCO Finland

Other rehabilitation service

1.8

17.2

286

1587

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

17.2

4584

40847

Z11

ICPC

Compliance/being ill problem

3.2

17.2

293

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

17.2

1847

15026

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

17.2

473

3031

29500

ICD-8 Finland

Schizophrenia, Simple type

6.1

17.2

A03CA02

ATC

clidinium and psycholeptics; oral

1.4

17.2

710

4980

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

17.1

718

5050

F25

ICD-10 Finland

Schizoaffective disorders

6.5

17.1

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.4

17.1

241

R03AC03

ATC

terbutaline; inhalant

1.3

17.1

1448

11430

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

17.0

377

2281

IHZ07

SPAT

4.3

17.0

143

S20

ICPC

Corn/callosity

1.9

17.0

234

1216

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.8

17.0

117

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.3

17.0

151

648

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.6

16.9

119

452

A27

ICPC

Fear of other disease NOS

1.6

16.9

459

2931

M35.7

ICD-10 Finland

Hypermobility syndrome

2.7

16.9

114

423

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

16.8

2783

23736

D09

ICPC

Nausea

1.7

16.8

354

2114

N27

ICPC

Fear of neurological disease other

2.3

16.7

158

698

J46

ICD-10 Finland

Status asthmaticus

1.8

16.7

285

1596

M02AA10

ATC

ketoprofen; topical

1.3

16.7

1752

14213

N88

ICPC

Epilepsy

3.6

16.6

205

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

16.6

479

3108

A02BA04

ATC

nizatidine; systemic

1.4

16.5

903

6667

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

16.5

3316

28809

UJD02

NOMESCO Finland

Gastroscopy

1.5

16.5

534

3559

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

4.4

16.4

135

Z08

ICPC

Social welfare problem

2.5

16.4

129

521

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.2

16.3

174

814

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

16.3

669

4685

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

16.3

982

7369

R25.3

ICD-10 Finland

Fasciculation

4.6

16.2

123

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

16.2

1261

9832

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.0

16.2

208

1052

U13

ICPC

Bladder symptom/complaint other

1.7

16.2

324

1906

N05AC01

ATC

periciazine; systemic

3.7

16.1

195

SPAT1285

SPAT

Provision of consultation response

1.5

16.1

588

4022

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

16.1

793

5746

N05AH05

ATC

asenapine; oral

8.7

16.1

G62.8

ICD-10 Finland

Other specified polyneuropathies

2.8

16.1

100

353

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

16.1

959

7183

R21

ICPC

Throat symptom/complaint

1.3

16.1

1702

13817

J01MA06

ATC

norfloxacin; oral

1.3

16.0

1500

11987

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

16.0

554

3748

N05BA05

ATC

potassium clorazepate; oral

2.5

16.0

126

508

F20.08

ICD-10 Finland

Paranoid schizophrenia other definite

6.1

16.0

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

16.0

2464

20857

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.0

15.9

206

1045

L01BC06

ATC

capecitabine; oral

0.5

15.9

129

2525

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.8

15.9

266

1479

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

15.9

744

5346

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

15.8

336

2011

M54.8

ICD-10 Finland

Other dorsalgia

1.6

15.8

373

2298

R31

ICD-10 Finland

Unspecified haematuria

1.3

15.8

1139

8786

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

5.5

15.8

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.4

15.7

131

546

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

15.7

957

7197

N05AB01

ATC

dixyrazine; systemic

2.3

15.7

145

635

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

15.6

373

2307

N86

ICPC

Multiple sclerosis

3.3

15.6

243

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

15.6

1110

8547

R06AE09

ATC

levocetirizine; oral

1.3

15.5

1332

10526

C07AA07

ATC

sotalol; systemic

1.5

15.5

465

3047

F02.3

ICD-10 Finland

Dementia in Parkinson disease

160.1

15.5

SPAT1237

SPAT

Psychotherapy

3.7

15.5

177

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

15.5

689

4907

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

5.4

15.5

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

15.4

666

4711

F41.3

ICD-10 Finland

Other mixed anxiety disorders

2.7

15.4

104

385

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

4.7

15.4

112

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

15.3

1101

8486

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

1.9

15.3

210

1090

S06

ICPC

Rash localized

1.5

15.3

570

3917

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.9

15.3

214

1121

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.8

15.3

169

A03

ICPC

Fever

1.3

15.3

1391

11078

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

5.0

15.2

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.1

15.2

168

798

G35

ICD-10 Finland

Multiple sclerosis

2.3

15.2

145

645

A97

ICPC

No disease

1.3

15.1

1562

12638

IHZ04

SPAT

4.3

15.1

128

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.6

15.1

111

434

SPAT1172

SPAT

Guidance concerning hydration

1.8

15.1

272

1552

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

15.1

1919

15908

R06.2

ICD-10 Finland

Wheezing

1.6

15.0

415

2668

30188

ICD-8 Finland

Personality disorders, Alia definita

3.7

15.0

172

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.1

15.0

267

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

15.0

1209

9474

R06AX27

ATC

desloratadine; oral

1.2

15.0

2524

21539

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.8

14.9

278

1600

R74

ICPC

Upper respiratory infection acute

1.2

14.9

2507

21388

IEV99

NOMESCO Finland

Other psychiatric network intervention

5.5

14.9

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.7

14.8

102

384

F61

ICD-10 Finland

Mixed and other personality disorders

3.7

14.8

169

SPAT1106

SPAT

Acupuncture

2.9

14.8

309

N02CC07

ATC

frovatriptan; oral

1.7

14.8

275

1585

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.8

14.8

348

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.0

14.7

196

1006

2962E

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCH.BIPOLARIS MANICA,VAIKEA-ASTE,PSYKOOT PIIRTEIT]

8.2

14.7

G72.9

ICD-10 Finland

Myopathy, unspecified

2.8

14.7

350

K11.72

ICD-10 Finland

Xerostomia

9.1

14.6

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

7.4

14.6

F20.19

ICD-10 Finland

Hebefren schizophrenia UNS

6.8

14.6

F06.7

ICD-10 Finland

Mild cognitive disorder

1.7

14.6

291

1711

G23.3

ICD-10 Finland

Multiple system atrophy, cerebellar type [MSA-C]

+∞

14.6

L09

ICPC

Arm symptom/complaint

1.6

14.6

416

2693

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.8

14.6

238

1317

L29.9

ICD-10 Finland

Pruritus, unspecified

1.8

14.5

237

1307

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

14.5

1333

10622

R06.4

ICD-10 Finland

Hyperventilation

2.1

14.5

161

769

F95.9

ICD-10 Finland

Tic disorder, unspecified

11.8

14.5

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.1

14.5

156

736

F60.7

ICD-10 Finland

Dependent personality disorder

3.8

14.4

163

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

7.2

14.4

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

14.4

3890

34589

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

14.4

296

1759

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.5

14.4

455

3019

J01CE02

ATC

phenoxymethylpenicillin; oral

1.1

14.3

8039

75402

F21

ICD-10 Finland

Schizotypal disorder

3.4

14.3

195

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

2.7

14.3

361

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

14.3

1340

10711

IGV01

NOMESCO Finland

Psychiatric network contact

3.5

14.3

185

N18

ICPC

Paralysis/weakness

1.9

14.2

209

1113

P18

ICPC

Medication abuse

3.8

14.2

160

RF120

NOMESCO Finland

2.3

14.1

130

571

IER01

NOMESCO Finland

Psychoeducation, group

4.3

14.1

118

C05AA08

ATC

fluocortolone; rectal, topical

1.3

14.1

1533

12474

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

4.0

14.1

137

M41.9

ICD-10 Finland

Scoliosis, unspecified

2.2

14.1

137

617

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.1

14.0

150

705

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

6.9

14.0

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

14.0

943

7196

R01AD01

ATC

beclometasone; nasal

1.3

14.0

1543

12574

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.8

14.0

321

K08.80

ICD-10 Finland

Toothache NOS

1.4

14.0

665

4795

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

13.9

818

6110

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

4.0

13.9

134

A06AX04

ATC

linaclotide; oral

4.6

13.9

102

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.9

13.9

144

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

13.9

607

4310

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.6

13.8

325

2006

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

13.8

1038

8052

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.3

13.8

1220

9671

K04.08

ICD-10 Finland

Other specified pulpit

1.5

13.8

492

3353

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

13.8

2175

18424

L04

ICPC

Chest symptom/complaint

1.4

13.8

551

3844

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

13.8

3225

28319

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

13.8

1066

8301

Z60.8

ICD-10 Finland

Other problems related to social environment

4.4

13.8

112

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

13.7

167

830

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

13.7

182

937

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.6

13.7

148

2665

H01

ICPC

Ear pain/earache

1.3

13.6

945

7244

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.6

13.6

391

2541

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

5.1

13.6

M70.7

ICD-10 Finland

Other bursitis of hip

1.7

13.6

262

1530

G25.4

ICD-10 Finland

Drug-induced chorea

+∞

13.5

F0234, G20

ICD-10 Finland

+∞

13.5

F023, G20

ICD-10 Finland

+∞

13.5

34209

ICD-8 Finland

+∞

13.5

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

13.5

1847

15415

29630

ICD-8 Finland

Affective psychoses, Manic-depressive psychosis, circular type

7.9

13.5

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

13.5

952

7316

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.7

13.5

252

1454

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

13.5

719

5288

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

4.6

13.5

101

H50.31

ICD-10 Finland

Intermittent exotropia

3.0

13.5

264

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

2.8

13.5

321

P80

ICPC

Personality disorder

4.0

13.4

129

H26.4

ICD-10 Finland

After-cataract

1.3

13.4

1046

8157

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

4.3

13.4

115

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

13.4

1086

8513

R63.1

ICD-10 Finland

Polydipsia

4.6

13.4

J02AC02

ATC

itraconazole; systemic

1.2

13.4

1848

15437

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

5.1

13.4

WX723

NOMESCO Finland

CPAP therapy

1.6

13.4

305

1867

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

13.4

878

6679

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

4.3

13.4

111

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.8

13.3

316

F33

ICD-10 Finland

Recurrent depressive disorder

2.2

13.3

135

621

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.7

13.3

256

1491

M01AB55

ATC

diclofenac, combinations; oral

1.4

13.2

770

5746

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

13.2

1830

15291

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

13.2

413

2734

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

13.2

341

2154

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.7

13.2

274

1633

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

13.2

2263

19321

ZYC01

SPAT

1.5

13.2

494

3405

IAB01

SPAT

6.3

13.1

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.4

13.1

755

5624

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.2

13.1

138

644

X58

ICD-10 Finland

Exposure to other specified factors

1.3

13.1

1272

10208

J01FA10

ATC

azithromycin; systemic

1.1

13.1

6290

58216

L76

ICPC

Fracture: other

1.7

13.0

286

1731

S01

ICPC

Pain/tenderness of skin

1.5

13.0

427

2860

G43

ICD-10 Finland

Migraine

1.7

13.0

274

1643

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

13.0

381

2487

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.9

13.0

260

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

13.0

561

3974

N05AB02

ATC

fluphenazine; systemic

2.7

13.0

311

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.5

13.0

122

2286

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

12.8

293

1796

J01MA12

ATC

levofloxacin; systemic

1.2

12.8

2102

17864

Z01.7

ICD-10 Finland

Laboratory examination

1.3

12.8

1121

8880

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

12.7

443

3003

C10AA01

ATC

simvastatin; oral

1.1

12.7

5623

51712

F28

ICD-10 Finland

Other nonorganic psychotic disorders

4.8

12.7

H92.0

ICD-10 Finland

Otalgia

1.5

12.7

438

2964

G04CB02

ATC

dutasteride; oral

1.4

12.7

703

5204

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

12.7

1883

15848

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

12.7

1336

10827

M01AX05

ATC

glucosamine; oral

1.2

12.7

2420

20860

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

4.3

12.6

108

29540

ICD-8 Finland

Acute schizophrenia episode

4.7

12.6

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.2

12.6

1704

14197

D01AE16

ATC

amorolfine; topical

1.3

12.6

1259

10137

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

12.6

1138

9049

R26

ICD-10 Finland

Abnormalities of gait and mobility

4.2

12.6

113

ZXA05

NOMESCO Finland

Left side

1.2

12.6

2982

26186

N89

ICPC

Migraine

1.9

12.6

189

1016

E66.8

ICD-10 Finland

Other obesity

1.5

12.5

421

2834

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

12.5

377

2476

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

3.4

12.5

179

G22

ICD-10 Finland

Parkinsonism in diseases classified elsewhere

+∞

12.5

G03DC03

ATC

lynestrenol; oral

1.9

12.5

174

910

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.5

12.5

466

3209

R49.01

ICD-10 Finland

Functional dysphonia

1.6

12.5

286

1757

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

12.5

784

5926

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.6

12.4

328

2089

IFA99

SPAT

7.3

12.4

J20

ICD-10 Finland

Acute bronchitis

1.3

12.4

932

7228

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

12.4

2276

19542

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.0

12.4

152

759

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

12.4

725

5417

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.3

12.4

115

509

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

3.1

12.4

213

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

3.5

12.3

160

F21

ICPC

2.4

12.3

103

433

IEY01

NOMESCO Finland

Psychoeducation, individual

3.6

12.3

150

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.8

12.3

201

1116

N06BA07

ATC

modafinil; oral

4.3

12.3

102

XF404

NOMESCO Finland

Ambulatory ECG

1.3

12.3

1015

7978

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.5

12.3

365

2389

K02.2

ICD-10 Finland

Caries of cementum

1.5

12.2

440

3008

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

12.2

2009

17073

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

12.2

842

6451

XF402

NOMESCO Finland

ECG with work load test

1.3

12.2

1234

9952

A07EA06

ATC

budesonide; oral, local oral

1.6

12.2

298

1859

P58

ICPC

Psychological, Therapeutic counselling/listening

2.2

12.2

119

539

P27

ICPC

Fear of mental disorder

2.5

12.2

366

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.2

12.2

117

528

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.2

12.2

1470

12104

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

3.9

12.2

122

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.3

12.1

815

6219

N48.1

ICD-10 Finland

Balanoposthitis

1.8

12.1

201

1118

IEV99

SPAT

7.4

12.1

A98

ICPC

Health maint/preventive medicine

1.2

12.1

12779

124574

H02AB07

ATC

prednisone; oral

1.2

12.1

1543

12780

IEY06

NOMESCO Finland

Psychiatric treatment and rehabilitation coaching

6.3

12.1

359

Kela drug reimbursment

Mirabegroni

2.6

12.1

319

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.5

12.1

408

2752

F30.20

ICD-10 Finland

Mania with mood-congruent psychotic symptoms

5.6

12.0

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.7

12.0

228

1328

N06DA02

ATC

donepezil; oral

1.4

12.0

597

4341

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.2

12.0

125

582

G04BD10

ATC

darifenacin; oral

2.5

12.0

353

M77.4

ICD-10 Finland

Metatarsalgia

1.4

12.0

474

3301

UJH02

NOMESCO Finland

Anoscopy

1.5

12.0

410

2773

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

12.0

4598

41842

R15

ICD-10 Finland

Faecal incontinence

1.6

11.9

274

1684

K88

ICPC

Postural hypotension

2.4

11.9

410

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.5

11.8

122

2223

F30.0

ICD-10 Finland

Hypomania

4.8

11.8

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

11.8

1120

8961

T90

ICPC

Diabetes non-insulin dependent

1.2

11.8

2604

22720

R25

ICD-10 Finland

Abnormal involuntary movements

11.7

11.8

F10.24

ICD-10 Finland

Alcohol depence active use

2.1

11.8

126

594

F60.5

ICD-10 Finland

Anankastic personality disorder

2.5

11.8

354

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.7

11.7

255

1545

M43.6

ICD-10 Finland

Torticollis

2.9

11.7

238

G01AF05

ATC

econazole; vaginal

1.4

11.7

669

4979

P15

ICPC

Chronic alcohol abuse

1.7

11.7

223

1300

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.6

11.7

281

1748

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

2.9

11.7

245

H02AB04

ATC

methylprednisolone; systemic

1.2

11.7

1539

12788

N02CC06

ATC

eletriptan; oral

1.7

11.7

233

1375

29830

ICD-8 Finland

Other psychoses, Acute paranoid reaction

4.1

11.6

108

XCK00

NOMESCO Finland

Perimetry

1.3

11.6

719

5423

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.3

11.6

780

5957

M41.4

ICD-10 Finland

Neuromuscular scoliosis

12.5

11.6

N02CC04

ATC

rizatriptan; oral

1.5

11.5

422

2895

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.1

11.5

191

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.4

11.5

545

3930

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.1

11.5

4152

37592

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

11.5

7515

70695

IAA02

SPAT

11.1

11.5

B35.1

ICD-10 Finland

Tinea unguium

1.4

11.5

524

3754

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.0

11.5

134

658

RF210

NOMESCO Finland

1.6

11.5

262

1607

K90

ICPC

Stroke/cerebrovascular accident

1.6

11.4

301

1914

R03BB04

ATC

tiotropium bromide; inhalant

1.3

11.4

1105

8863

AAG10

NOMESCO Finland

Stereotactic intracranial destruction of nucleus or nerve tract

120.1

11.4

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

11.4

471

3312

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.8

11.4

195

1100

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

11.4

409

2797

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

11.4

1965

16770

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.3

11.4

783

5999

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.6

11.4

184

2999

G50.0

ICD-10 Finland

Trigeminal neuralgia

1.9

11.4

155

808

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

2.5

11.4

332

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.7

11.4

267

WYA20

NOMESCO Finland

Home visit

1.9

11.3

167

895

K05.18

ICD-10 Finland

Chronic gingivitis

1.5

11.3

427

2949

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.0

11.3

148

759

SPAT1304

SPAT

Counselling and guidance related to ageing

1.3

11.3

797

6124

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

11.3

843

6533

R01AD12

ATC

fluticasone furoate; nasal

1.2

11.3

2755

24223

30088

ICD-8 Finland

Neuroses, Other

3.0

11.3

205

A04AA02

ATC

granisetron; systemic, transdermal

0.7

11.3

306

4485

S03.0

ICD-10 Finland

Dislocation of jaw

2.9

11.3

233

R40.0

ICD-10 Finland

Somnolence

3.7

11.3

126

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.6

11.2

270

1681

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

11.2

1618

13567

F51

ICD-10 Finland

Nonorganic sleep disorders

1.6

11.2

258

1585

G40

ICD-10 Finland

Epilepsy

2.5

11.2

346

H51.1

ICD-10 Finland

Convergence insufficiency and excess

4.5

11.2

F20.6

ICD-10 Finland

Simple schizophrenia

7.2

11.2

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.0

11.2

147

756

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.3

11.2

906

7104

RF420

NOMESCO Finland

2.0

11.2

134

666

R44.0

ICD-10 Finland

Auditory hallucinations

3.6

11.2

132

H82

ICPC

Vertiginous syndrome

1.8

11.2

177

972

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

5.4

11.1

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.4

11.1

485

3446

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.2

11.1

109

497

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

3.5

11.1

143

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

3.0

11.1

208

S02

ICPC

Pruritus

1.6

11.1

305

1964

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

11.1

2840

25067

M05BA04

ATC

alendronic acid; oral

1.3

11.0

937

7389

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.3

11.0

427

G93.3

ICD-10 Finland

Postviral fatigue syndrome

4.3

11.0

E87.6

ICD-10 Finland

Hypokalaemia

1.6

10.9

302

1947

S97

ICPC

Chronic ulcer skin

1.4

10.9

565

4138

2962C

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,KESKIVAIKEA]

7.4

10.9

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.9

10.9

110

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.5

10.9

349

2327

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

10.9

635

4743

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.9

10.9

165

894

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.4

10.9

490

3503

AA40B

NOMESCO Finland

2.9

10.8

222

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

3.1

10.8

189

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

10.8

2372

20664

ECB00

NOMESCO Finland

Suture of gingiva

1.5

10.8

330

2176

N04AB02

ATC

orphenadrine (chloride); systemic

11.9

10.8

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

2.6

10.8

306

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.3

10.8

438

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

3.9

10.8

111

G03DB01

ATC

dydrogesterone; oral

1.3

10.8

1036

8304

XQ800

NOMESCO Finland

Prick test

1.4

10.8

595

4406

30180

ICD-8 Finland

Personality disorders, Immatura

3.1

10.8

179

WZC00

SPAT

1.5

10.7

381

2599

R83

ICPC

Respiratory infection other

1.2

10.7

1910

16346

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

10.7

568

4178

U29

ICPC

Urinary symptom/complaint other

1.6

10.7

272

1718

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.5

10.7

320

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.3

10.7

736

5644

L75

ICPC

Fracture: femur

2.0

10.6

132

665

A85

ICPC

Adverse effect medical agent

2.2

10.6

103

467

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

3.4

10.6

143

G50.1

ICD-10 Finland

Atypical facial pain

1.9

10.6

161

873

E03

ICD-10 Finland

Other hypothyroidism

1.4

10.6

551

4040

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.8

10.6

178

997

X15

ICPC

Vaginal symptom/complaint other

1.7

10.6

231

1401

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

1.9

10.5

142

738

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

2.6

10.5

298

B07.9

ICD-10 Finland

Verruca simplex

1.6

10.5

272

1726

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

10.5

1022

8201

E61.1

ICD-10 Finland

Iron deficiency

2.2

10.5

105

484

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.8

10.5

181

1025

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.6

10.5

249

1548

R03AC13

ATC

formoterol; inhalant

1.4

10.5

486

3496

F20.12

ICD-10 Finland

Hebefren schizophrenia stable periodically

14.2

10.5

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

2.2

10.4

100

453

F84.5

ICD-10 Finland

Asperger syndrome

4.0

10.4

100

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.3

10.4

865

6808

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

4.4

10.4

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

10.3

569

4213

R49.03

ICD-10 Finland

Atrophic dysphonia

2.1

10.3

118

576

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.3

10.3

797

6212

G31.0

ICD-10 Finland

Circumscribed brain atrophy

3.0

10.3

199

IFA01

SPAT

8.2

10.3

29610

ICD-8 Finland

Affective psychoses, Manic-depression psychosis, manic type

4.9

10.3

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

10.3

512

3730

F30.9

ICD-10 Finland

Manic episode, unspecified

4.0

10.2

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

10.2

424

2985

K11.70

ICD-10 Finland

Hypoptyalism

2.6

10.2

273

DHB50

NOMESCO Finland

Turbinoplasty

1.7

10.2

204

1208

K29.7

ICD-10 Finland

Gastritis, unspecified

1.5

10.2

344

2320

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

3.3

10.2

148

K56.2

ICD-10 Finland

Volvulus

2.6

10.2

285

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

10.2

796

6211

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

1.9

10.2

151

812

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

10.2

182

1044

A03BA03

ATC

hyoscyamine; oral

2.2

10.2

102

469

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

10.2

967

7739

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

2.4

10.1

367

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

4.0

10.1

S01.8

ICD-10 Finland

Open wound of other parts of head

2.0

10.1

130

664

IEY19

NOMESCO Finland

Psychiatric health counselling and guidance

6.2

10.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.4

10.1

531

3902

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

10.1

1063

8615

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.0

10.1

130

667

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

5.4

10.1

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

4.7

10.1

XJH00

NOMESCO Finland

Transanal ultrasonography

1.3

10.1

696

5339

IGP01

NOMESCO Finland

Psychiatric family contact

3.4

10.1

134

A10BA02

ATC

metformin; oral

1.1

10.0

3215

28817

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

11.3

10.0

C01CA24

ATC

epinephrine; parenteral

1.4

10.0

474

3421

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.0

10.0

129

659

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.3

10.0

891

7073

AAG99

NOMESCO Finland

Other stereotactic intracranial operation

40.0

10.0

2956C

ICD-9 Finland

Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]

6.1

9.9

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.1

9.9

104

491

C01DA14

ATC

isosorbide mononitrate; oral

1.2

9.9

1916

16504

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

1.9

9.9

135

706

J01FF01

ATC

clindamycin; systemic

1.2

9.9

2873

25570

N02CA01

ATC

dihydroergotamine; nasal, systemic

2.9

9.9

194

K27

ICPC

Fear cardiovascular disease other

2.1

9.9

103

484

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.2

9.9

1428

11974

30041

ICD-8 Finland

Neuroses, Depressiva

1.9

9.9

139

738

P50

ICPC

Psychological, Medication/prescr/renewal

3.3

9.8

147

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.2

9.8

1489

12542

D01AC02

ATC

miconazole; topical

1.3

9.8

826

6509

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.2

9.8

564

N02CC05

ATC

almotriptan; oral

1.6

9.8

272

1758

EMAK

NOMESCO Finland

1.5

9.8

324

2181

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

5.2

9.8

2962D

ICD-9 Finland

Affective psychoses, Major depressive disorder, single episode[PSYCHOSIS BIPOLARIS MANICA,VAIKEA-ASTEINEN]

10.6

9.8

F80.1

ICD-10 Finland

Expressive language disorder

2.5

9.7

299

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.6

9.7

216

1320

S10

ICPC

Boil/carbuncle

1.4

9.7

490

3578

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

9.7

318

2136

Z72.2

ICD-10 Finland

Drug use

3.4

9.7

128

A01AB10

ATC

natamycin; local oral

1.6

9.7

272

1764

R4120

SPAT

4.0

9.7

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.3

9.6

606

4583

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.4

9.6

386

2701

T05

ICPC

Feeding problem of adult

2.6

9.6

269

R81

ICPC

Pneumonia

1.5

9.6

311

2085

N03AX18

ATC

lacosamide; systemic

2.6

9.6

246

R40.2

ICD-10 Finland

Coma, unspecified

2.2

9.5

436

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

3.6

9.5

114

Z03

ICPC

Housing/neighbourhood problem

2.5

9.5

272

OAB44

SPAT

1.5

9.5

295

1958

F20.20

ICD-10 Finland

Catatonic schizophrenia continuously

6.3

9.5

F29

ICPC

Eye symptom/complaint other

1.3

9.5

770

6041

N05AE02

ATC

molindone; oral

9.1

9.5

G01AF04

ATC

miconazole; vaginal

1.4

9.5

404

2862

K44

ICD-10 Finland

Diaphragmatic hernia

2.2

9.5

418

R04

ICPC

Breathing problem other

1.5

9.5

311

2089

P77

ICPC

Suicide/suicide attempt

5.7

9.5

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

3.3

9.5

141

H02

ICPC

Hearing complaint

1.2

9.5

1341

11224

M01AB08

ATC

etodolac; oral

1.3

9.4

698

5407

K05.1

ICD-10 Finland

Chronic gingivitis

1.3

9.4

591

4471

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

1.6

9.4

236

1488

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

4.8

9.4

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

9.4

1306

10904

29520

ICD-8 Finland

Schizophrenia, Catatonic type

6.6

9.4

I50

ICD-10 Finland

Heart failure

1.5

9.4

341

2340

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.8

9.4

154

858

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6756

43498

1.93

307.65

2.5

2.1

210.1

218.2

u/l

0.24

6338

40579

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

8423

59857

1.82

302.05

2.3

2.0

93.6

95.0

pmol/l

1.89

4669

30919

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8071

56723

1.82

299.28

3.2

2.9

119.3

143.0

ug/l

15.91

7309

51886

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9622

72493

1.77

270.54

6.2

6.7

1.2

mmol/l

1.81

8174

60678

(3009466) Valproate [Moles/volume] in Serum or Plasma

692

1658

4.31

260.25

6.2

4.4

385.0

355.3

umol/l

5.48

626

1376

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8849

65774

1.73

254.23

5.7

6.0

1.2

mmol/l

0.57

8022

59141

(3019309) Folate [Moles/volume] in Red Blood Cells

4651

29016

1.84

243.09

1.9

1.8

1202.9

1160.1

nmol/l

2.19

3524

21657

(3021960) Folate [Moles/volume] in Serum or Plasma

5264

34524

1.77

230.03

1.7

1.6

19.9

20.3

nmol/l

0.81

4562

29268

(3031040) Bacteria [#/volume] in Urine by Automated count

11349

92619

1.70

210.85

6.2

4.7

1876.2

1545.2

e6/l

0.22

173

1377

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12234

102434

1.73

200.87

4.7

4.0

15.0

14.9

pmol/l

3.13

11113

92104

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5351

36724

1.67

190.00

2.4

2.3

2.9

3.0

mg/l

3.97

4495

31227

(3015377) Calcium [Moles/volume] in Serum or Plasma

6661

48431

1.62

187.43

2.7

3.4

2.3

2.4

mmol/l

1.82

5709

41670

(3013707) Erythrocyte sedimentation rate by Westergren method

12025

101348

1.66

179.95

4.4

4.2

12.1

13.4

mm/h

18.05

11103

93135

(3018418) pH of Serum or Plasma

6003

43188

1.61

172.37

3.7

4.1

7.4

1.11

1025

8255

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

303

516

5.96

169.12

14.5

11.5

0.6

mmol/l

0.78

277

469

(3024561) Albumin [Mass/volume] in Serum or Plasma

8089

62575

1.57

168.86

4.2

4.8

35.4

35.0

g/l

7.28

7471

57791

(3026008) Bacteria identified in Urine by Culture

6158

44882

1.59

165.62

3.9

3.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13917

123181

1.78

160.65

5.9

4.8

1.9

2.1

mu/l

5.34

12794

111518

(3037467) Urinalysis macro (dipstick) panel - Urine

11362

95517

1.59

160.45

5.4

4.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

10125

82935

1.56

159.92

5.1

4.8

6.6

6.8

mmol/l

10.09

9571

77700

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

291

513

5.76

156.67

15.9

17.9

1483.2

1455.5

nmol/l

0.14

279

497

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4507

30955

1.62

152.54

1.7

20511870.6

30822871.1

pmol/l

0.79

3715

25157

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12406

107169

1.61

149.60

7.2

7.7

78.0

79.6

u/l

3.33

11666

100531

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

275

499

5.59

143.56

11.5

12.6

833.0

849.8

nmol/l

0.18

263

481

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

785

2979

2.72

140.92

1.3

540.3

541.3

mg/l

0.01

737

2827

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7300

57094

1.49

132.69

2.4

2.2

77.7

78.5

nmol/l

1.64

6453

50511

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7077

55177

1.49

129.61

4.6

3.8

49.7

72.0

ng/l

0.87

5231

39818

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3494

23340

1.63

128.85

2.6

3.3

0.8

mmol/l

8.29

3181

21640

(3006315) Basophils [#/volume] in Blood

8441

68491

1.47

124.37

6.1

5.8

0.0

e9/l

5.56

7270

58617

(3035350) Ketones [Presence] in Urine by Test strip

8307

67196

1.47

124.35

4.7

3.8

0.0

estimate

1.28

1520

12451

(3013115) Eosinophils [#/volume] in Blood

8661

70643

1.47

124.13

6.6

6.0

0.2

e9/l

5.02

7587

61348

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

691

2620

2.71

124.07

1.2

1.3

3.8

mmol/l

0.51

640

2453

(3001604) Monocytes [#/volume] in Blood

8400

68137

1.47

123.68

6.0

5.8

0.6

e9/l

14.28

7245

58285

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3547

24027

1.60

122.66

2.0

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

8538

69927

1.45

116.65

6.2

5.8

1.9

e9/l

0.36

7486

60934

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

678

2627

2.65

116.54

1.3

1.4

7.0

31.9

e6/l

3.60

501

2044

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

677

2629

2.64

115.84

1.4

1.5

557.9

3376.8

e6/l

1.09

537

2151

(3021601) Nitrite [Presence] in Urine by Test strip

8256

67343

1.45

114.32

6.2

5.2

0.0

estimate

1.60

1558

12611

(3023368) Bacteria identified in Blood by Culture

5376

40419

1.49

113.74

4.5

4.4

—

(3009261) Glucose [Presence] in Urine by Test strip

8330

68110

1.44

113.55

4.8

3.9

0.0

estimate

0.04

1527

12331

(3013650) Neutrophils [#/volume] in Blood by Automated count

9439

79214

1.44

110.30

9.3

9.0

4.2

e9/l

0.06

8246

68752

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5772

44313

1.46

108.45

2.6

55.0

59.2

u/l

7.92

5284

40705

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2558

16483

1.65

106.58

1.9

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3836

27189

1.53

106.40

2.7

3.1

2.4

2.5

mmol/l

9.82

3328

23656

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

325

876

3.76

103.53

1.1

282.5

291.6

mg/l

1.39

294

779

(3044290) Cell count panel - Cerebral spinal fluid

617

2422

2.61

103.19

1.3

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2542

16497

1.64

102.60

1.9

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8814

73692

1.41

101.00

5.1

6.2

10.9

11.7

umol/l

6.42

8302

69718

(3011397) Hemoglobin [Presence] in Urine by Test strip

4381

32335

1.48

98.63

4.6

3.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

173

294

5.94

96.81

1.6

1.2

112.6

136.6

nmol/l

0.94

112

222

(3022948) Iron [Moles/volume] in Serum or Plasma

3310

23174

1.53

95.68

2.4

2.5

13.1

12.5

umol/l

3.96

2990

21340

(3019150) Specific gravity of Urine by Refractometry

4046

29581

1.49

94.84

5.3

4.3

1.0

kg/l

0.31

603

4635

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

182

331

5.55

94.83

2.9

2.3

152.7

150.6

nmol/l

0.07

155

289

(36304419) Bacteria [Presence] in Urine

5083

38854

1.44

94.46

3.6

3.2

—

(3018095) Leukocytes [#/volume] in Urine

6356

50622

1.41

93.76

4.4

3.8

108.2

106.0

e6/l

0.06

4699

36294

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

14550

134605

1.63

92.88

19.5

15.7

23.6

25.1

mg/l

6.34

12296

108383

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3767

27356

1.49

90.65

1.3

1.7

u/ml

0.12

953

7103

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1935

12056

1.68

90.64

2.1

2.2

376.7

376.9

nmol/l

0.01

1757

11022

(3030467) Casts [#/volume] in Urine by Automated count

5219

40320

1.43

90.62

3.6

3.3

0.3

0.5

e6/l

5.64

4071

30541

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1460

8581

1.77

84.10

2.5

2.4

34.0

25.7

au/ml

0.96

401

(3019550) Sodium [Moles/volume] in Serum or Plasma

14937

139712

1.65

83.75

22.6

18.3

139.6

mmol/l

0.28

14655

136057

(3002582) Erythrocytes [#/volume] in Urine

5561

43955

1.40

82.83

3.8

3.3

70.1

98.6

e6/l

1.09

4383

33872

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3998

29814

1.45

82.62

1.8

1.7

1.2

1.3

mg/l

1.42

3042

23033

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2060

13339

1.62

82.40

1.9

1.7

1.5

1.62

1785

11447

(42870588) Differential panel, method unspecified - Blood

5949

47614

1.39

81.98

5.7

5.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

14950

140014

1.64

81.54

22.7

18.4

4.0

mmol/l

2.58

14652

136119

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1345

7791

1.79

81.32

1.3

67.7

50.9

au/ml

0.96

330

(3022096) Basophils/100 leukocytes in Blood

7489

62307

1.37

80.70

6.2

6.1

0.7

1.73

6912

57703

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3030

21503

1.50

80.32

2.3

2.5

2.4

2.3

g/l

5.50

2731

19797

(3000850) Epithelial cells [#/volume] in Urine

4087

30787

1.43

79.40

2.8

2.7

5.2

5.3

e6/l

0.38

3597

26883

(3028707) Methadone [Presence] in Urine by Screen method

372

1287

2.93

79.21

2.9

2.6

—

(3006504) Eosinophils/100 leukocytes in Blood

7668

64153

1.36

79.16

6.1

6.0

2.8

2.9

2.12

7076

59357

(3019069) Monocytes/100 leukocytes in Blood

7699

64496

1.36

78.60

6.4

6.3

8.5

8.7

6.99

7117

59963

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9749

84741

1.36

78.14

3.6

3.1

47.3

51.1

u/l

3.30

9008

77975

(3029937) Albumin [Presence] in Urine by Test strip

4730

36691

1.40

77.44

5.4

4.3

0.0

estimate

0.14

1503

12061

(3018010) Neutrophils/100 leukocytes in Blood

7727

64896

1.35

76.96

6.1

5.9

58.2

57.9

1.91

7132

60216

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1425

8528

1.73

76.74

1.6

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

256

726

3.57

75.69

1.1

6.3

7.3

nmol/l

0.07

156

(3002030) Lymphocytes/100 leukocytes in Blood

7814

65936

1.35

74.51

6.3

6.2

26.9

27.1

0.82

7174

60939

(3001186) Copper [Moles/volume] in Serum or Plasma

139

256

5.47

71.51

1.1

1.4

16.5

17.1

umol/l

0.63

124

232

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

5515

44362

1.36

70.80

3.1

1287.9

1608.7

ng/l

5.75

4709

38325

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6273

51569

1.35

69.50

5.2

4.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3328

24900

1.42

65.06

3.1

2.8

1.2

1.3

e6/l

0.13

1987

14331

(3032080) INR in Blood by Coagulation assay

7113

59958

1.32

64.87

9.2

9.8

1.2

1.3

inr

4.82

1993

16631

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2776

20183

1.45

63.28

2.5

2.6

22.3

22.0

0.54

2290

17074

(3033942) Copper [Moles/time] in 24 hour Urine

16.82

62.51

1.0

1.3

0.3

1.2

umol/24h

0.66

(3003396) Base excess in Arterial blood by calculation

2400

17027

1.48

61.99

5.6

6.9

1.5

1.1

mmol/l

7.51

1929

13323

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1417

8940

1.64

61.96

1.8

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2396

17044

1.47

60.96

5.6

6.9

11.7

12.2

kpa

4.56

2271

16193

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2397

17053

1.47

60.95

5.6

6.9

5.2

5.1

kpa

4.99

2280

16213

(3023410) Appearance of Cerebral spinal fluid

315

1163

2.74

59.46

1.4

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

333

1267

2.66

59.27

1.3

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

252

828

3.07

58.83

1.2

1.1

37.1

41.8

mg/l

0.92

206

703

(3019060) Gas panel - Arterial blood

1528

9957

1.59

58.33

4.2

4.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

314

1171

2.71

58.14

1.1

71.3

73.2

au/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

3196

24156

1.40

58.02

1.5

2.3

2.5

g/l

9.02

1757

14212

(40761535) Cells panel - Urine sediment

1781

12030

1.54

57.99

3.9

3.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

260

881

2.98

57.53

1.0

36.6

44.0

ng/l

1.70

170

595

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

8613

75270

1.30

57.38

2.9

2.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

259

878

2.98

57.27

1.0

735.1

711.6

ng/l

0.33

171

585

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

258

875

2.98

57.00

1.0

258.6

340.9

ng/l

6.11

175

600

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

242

792

3.09

56.90

1.1

246.6

281.1

mg/l

1.97

209

698

(3026782) Osmolality of Urine

3707

28830

1.37

56.28

3.1

2.9

541.0

545.7

mosm/kgh2o

0.66

3125

24530

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5272

43240

1.32

55.87

3.2

30.4

34.9

u/l

7.49

4914

40820

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1437

9327

1.59

55.67

6.3

7.0

25.2

24.6

mmol/l

9.98

1356

8686

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

232

761

3.08

54.35

1.1

—

(3016502) Oxygen saturation in Arterial blood

2144

15274

1.46

53.55

5.8

7.2

95.3

95.5

1.07

2054

14684

(40758558) Short blood count panel - Blood

4348

34934

1.33

52.55

6.8

6.9

—

(3011288) Drugs identified in Urine by Screen method

421

1920

2.22

50.31

3.8

2.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

876

5132

1.75

50.30

2.1

2.3

637.9

579.5

ug/l

0.08

810

4825

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

165

5.66

49.89

2.1

1.8

17.2

16.7

umol/l

0.14

165

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13323

124554

1.34

48.60

6.7

6.1

40.1

40.2

mmol/mol

1.26

12260

113932

(1001926) Buprenorphine [Presence] in Urine by Screen method

465

2240

2.11

48.37

2.7

2.1

—

(40761511) CBC panel - Blood by Automated count

14587

138404

1.42

48.32

18.4

14.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3608

28518

1.34

48.03

4.3

3.9

241.9

475.6

ng/l

3.72

2821

23175

(3044889) 12 lead EKG panel

10591

96165

1.28

47.26

4.5

4.0

—

(4027681)

191

609

3.16

47.01

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

557

2894

1.96

46.99

2.3

2.5

30.3

34.0

umol/l

3.51

460

2413

(40768797) Stomach Pathology biopsy report

2564

19284

1.39

46.74

1.3

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1943

13930

1.45

46.46

6.2

7.7

122.1

120.5

g/l

2.82

1876

13431

(3048689) Calprotectin [Mass/mass] in Stool

2073

15043

1.43

46.41

2.0

2.2

146.2

140.5

ug/g

0.26

1609

11662

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

269

1044

2.60

46.08

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2986

23159

1.35

44.65

3.4

3.0

2.9

2.6

e6/l

0.75

1655

12695

(3051339) Copper [Moles/volume] in Blood

9.32

44.42

1.2

1.1

16.0

17.2

umol/l

1.38

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2870

22142

1.36

44.39

1.3

32.0

37.6

iu/ml

1.06

813

6941

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13830

130473

1.35

44.03

5.3

4.8

6.0

mmol/l

0.37

12545

117618

(3043409) Potassium [Moles/volume] in Arterial blood

761

4453

1.74

43.81

3.9

4.3

3.9

mmol/l

1.27

723

4174

(3016879) Cocaine [Presence] in Urine

520

2709

1.95

43.53

2.7

2.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

854

5221

1.67

41.82

3.8

4.0

1.3

1.4

mmol/l

2.15

841

5129

(3020891) Body temperature

938

5878

1.63

41.68

4.9

4.7

—

(3000764) Benzodiazepines [Presence] in Urine

542

2913

1.89

41.31

2.7

2.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1782

12846

1.43

41.04

5.5

6.6

1.3

1.4

mmol/l

0.75

1721

12329

(3020630) Protein [Mass/volume] in Serum or Plasma

1759

12657

1.44

40.91

2.0

2.6

66.4

66.2

g/l

0.53

1559

11387

(3028300) Cannabinoids [Presence] in Urine

542

2937

1.87

40.28

2.7

2.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1540

10851

1.46

40.01

1.7

1.6

—

(3027008) Opiates [Presence] in Urine

540

2932

1.87

39.88

2.7

1.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1196

8024

1.53

39.53

2.9

3.3

4.4

pmol/l

0.20

1026

7072

(3033658) Prothrombin time (PT) actual/Normal

4315

35723

1.28

39.40

4.0

87.9

88.0

0.07

4189

34829

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

236

937

2.54

38.65

1.2

1.3

1.9

2.2

mmol/l

3.04

219

867

(40760892) CBC W Ordered Manual Differential panel - Blood

3556

28788

1.30

38.51

4.7

4.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1489

10515

1.46

38.16

1.9

2.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2277

17335

1.36

37.75

2.3

2.4

1.7

1.8

3.40

1934

15235

(3027944) Amphetamines [Presence] in Urine

524

2874

1.85

37.49

2.5

1.9

—

(4198724)

127

362

3.53

37.48

2.1

2.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2859

22591

1.32

36.78

2.0

2.1

29.8

30.0

0.71

2774

21901

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1566

11250

1.43

36.53

3.2

3.8

85.4

92.8

ng/l

2.14

1325

9570

(3037522) Nuclear Ab [Titer] in Serum

2282

17479

1.35

36.25

1.4

1.3

547.5

536.0

titre

0.10

449

3807

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

212

828

2.58

35.95

1.8

1.4

14.6

12.7

umol/l

2.93

206

774

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2344

18060

1.35

35.77

9.0

7.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2651

20841

1.32

35.18

1.3

9.1

14.1

u/ml

3.54

987

7654

(3014576) Chloride [Moles/volume] in Serum or Plasma

2387

18520

1.34

34.66

6.0

6.8

104.4

mmol/l

0.06

2333

18112

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

271

1204

2.27

34.61

1.4

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2454

19122

1.33

34.59

4.7

5.7

1.0

mmol/l

2.29

2242

17677

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14823

142316

1.37

34.38

11.8

10.9

23.8

25.7

u/l

27.62

14226

136645

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1336

9445

1.45

33.89

3.7

5.2

5.1

kpa

3.39

1229

8688

(4034850)

710

4376

1.65

33.64

11.9

10.6

—

(36660697) Celiac disease serology panel - Serum

1386

9880

1.44

33.62

1.2

—

(3009343) pH of Capillary blood

1319

9319

1.45

33.56

3.7

7.4

1.07

197

1190

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1278

9000

1.45

33.06

3.7

3.6

2.0

1.8

mmol/l

1.38

973

6669

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1728

12872

1.38

32.49

2.4

2.5

33.2

49.6

u/l

1.63

1446

10977

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1837

13822

1.37

32.45

4.0

3.9

5.9

5.8

kpa

1.96

1771

13400

(3002032) Base excess in Venous blood by calculation

1828

13799

1.36

31.59

4.1

3.9

2.2

1.9

mmol/l

3.98

1529

11205

(3022217) INR in Platelet poor plasma by Coagulation assay

2582

20506

1.31

31.48

27.7

27.4

1.3

1.4

inr

1.42

277

2876

(3015171) Extractable nuclear Ab [Units/volume] in Serum

782

5019

1.59

31.38

1.2

1.0

u/ml

0.01

107

453

(3021589) Normoblasts [#/volume] in Blood

6772

60025

1.22

31.35

10.7

10.1

0.0

e9/l

0.22

5480

49033

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

632

3853

1.67

31.24

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1762

13249

1.37

31.19

2.6

2.4

5.3

7.0

ug/l

5.81

1431

11426

(3007853) Bacteria identified in Skin by Aerobe culture

2149

16666

1.33

31.02

1.9

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

1541

11349

1.39

30.96

3.5

3.3

4.5

kpa

0.44

1482

10945

(3000494) Fungus identified in Specimen by Culture

2069

15980

1.34

30.69

1.5

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1295

9269

1.43

30.63

6.7

8.5

1.4

1.73

1285

9205

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1291

9242

1.43

30.50

6.8

8.6

0.7

3.49

1283

9178

(3014765) Yersinia sp identified in Stool by Organism specific culture

632

3897

1.65

29.89

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

633

3909

1.64

29.76

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

528

3113

1.72

29.58

1.8

1.7

315.0

299.7

mu/l

0.44

477

2835

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

546

3260

1.70

29.21

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

546

3260

1.70

29.21

1.4

1.3

—

(3012544) pH of Venous blood

1866

14333

1.34

28.60

4.0

3.9

7.4

0.17

(3044640) Blood type and Crossmatch panel - Blood

5168

44926

1.22

28.28

2.4

2.5

—

(3019225) pH of Specimen

1913

14782

1.33

28.12

4.4

4.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7247

65094

1.20

28.02

4.0

4.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

153

578

2.66

27.86

1.1

1.0

1.1

u/l

1.12

273

(3000991) Gas panel - Venous blood

1625

12313

1.35

27.19

6.6

7.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

983

6931

1.44

25.13

3.2

2.8

1.2

0.28

977

6896

(3000570) Elastase.pancreatic [Mass/mass] in Stool

654

4241

1.56

25.09

1.4

283.8

268.0

ug/g

1.21

408

2510

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

13227

126241

1.23

24.50

17.2

14.8

79.1

77.3

ml/min/173m2

18.27

11143

104533

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

174

751

2.33

23.93

1.4

1.5

5.4

6.3

u/l

1.13

145

626

(3007461) Platelets [#/volume] in Blood

15188

147448

1.33

23.77

29.2

23.0

246.0

247.7

e9/l

2.45

14883

143154

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

957

6788

1.43

23.67

3.2

2.8

0.7

0.68

917

6514

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

159

664

2.41

23.57

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

634

4148

1.55

23.39

1.7

—

(3035941) MCH [Entitic mass]

15189

147500

1.33

23.38

29.1

22.9

30.4

0.09

15001

145024

(3024731) MCV [Entitic volume]

15189

147516

1.33

23.24

29.1

22.9

91.5

91.3

3.71

15000

145041

(3024869) Neuronal Ab [Presence] in Serum

256

3.33

23.20

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

15189

147526

1.32

23.14

29.2

23.0

4.4

e12/l

14.34

14829

142734

(3000963) Hemoglobin [Mass/volume] in Blood

15191

147549

1.32

23.13

29.4

23.1

132.9

134.0

g/l

20.07

14999

145088

(1002224) Polysomnography panel

657

4344

1.53

23.11

1.1

—

(3010813) Leukocytes [#/volume] in Blood

15189

147548

1.32

22.94

29.3

23.0

6.8

e9/l

0.38

14840

142753

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.11

22.77

5.5

9.9

—

(3014271) Vancomycin [Susceptibility]

189

863

2.20

22.76

3.5

3.0

—

(3023520) Reticulocytes [#/volume] in Blood

1677

13092

1.31

22.66

2.3

2.5

67.3

69.2

e9/l

1.46

1295

9945

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

101

343

2.96

22.55

1.8

2.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

208

3.57

22.48

1.2

1.0

—

(4010399)

1343

10199

1.34

21.98

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

154

659

2.35

21.65

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

828

5815

1.45

21.60

4.1

4.0

25.1

24.9

mmol/l

1.77

764

5306

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1071

7883

1.38

21.38

1.3

1.2

100.4

143.1

iu/ml

3.47

405

2865

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

863

6124

1.43

21.28

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

197

3.56

21.24

1.2

1.0

6.0

7.7

mg/g

1.39

185

(3020961) Endomysium IgA Ab [Titer] in Serum

797

5579

1.45

21.16

1.2

1.1

487.8

209.8

titre

0.87

132

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

651

4413

1.49

20.36

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

825

5874

1.43

19.97

1.3

—

(3042936) Bacteria identified in Isolate by Culture

2431

20169

1.24

19.80

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

153

680

2.26

19.74

1.1

—

(3022313) Gas panel - Capillary blood

924

6738

1.39

19.50

3.9

3.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

153

687

2.24

19.28

2.8

2.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

122

496

2.47

19.26

1.2

1.8

29.9

29.6

umol/l

0.11

114

478

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

948

6972

1.38

19.00

3.8

4.3

24.6

24.1

mmol/l

5.01

831

6271

(3004119) Hemoglobin [Mass/volume] in Venous blood

1177

8954

1.34

18.98

3.6

3.4

128.5

127.6

g/l

0.74

1150

8731

(3005322) IgE [Units/volume] in Serum or Plasma

1009

7507

1.37

18.82

1.3

193.2

230.4

u/ml

0.45

933

6866

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3922

34261

1.19

18.66

2.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1157

8823

1.33

18.34

1.2

—

(3013512) EKG study

4757

42292

1.17

18.29

4.6

4.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1294

10030

1.31

18.29

2.5

2.8

10.3

10.6

g/l

1.67

1169

9158

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

590

4009

1.49

18.27

1.6

1.2

g/l

0.07

559

3782

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

773

5533

1.42

18.17

2.0

2.3

9.8

10.3

g/l

2.21

632

4579

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

586

3981

1.49

18.16

1.6

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

816

5901

1.40

18.09

2.0

2.3

3.7

3.8

g/l

1.65

581

4146

(44816559) Phosphatidylethanol [Mass/volume] in Blood

351

2123

1.67

18.03

1.4

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

817

5920

1.40

17.90

2.0

2.3

7.1

7.5

g/l

6.41

595

4335

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

628

4338

1.47

17.90

2.2

2.3

0.0

g/l

0.61

568

3913

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

768

5507

1.41

17.88

2.0

2.4

3.0

3.1

g/l

3.15

591

4227

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

815

5913

1.40

17.73

2.0

2.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

722

5134

1.42

17.62

1.1

1.7

4.9

u/ml

0.47

(3023511) Choriogonadotropin [Units/volume] in Urine

245

1348

1.83

17.58

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

627

8894

0.69

17.54

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4041

35554

1.18

17.48

4.4

3.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1961

16094

1.25

17.47

2.5

2.7

6.7

9.0

umol/l

9.04

1643

13962

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

570

3886

1.48

17.37

1.6

0.2

g/l

1.06

536

3655

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

701

4978

1.43

17.24

2.1

2.5

0.5

1.0

g/l

3.87

595

4186

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

905

6711

1.37

17.23

4.5

4.1

50.6

47.4

3.74

892

6629

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

775

5607

1.40

17.14

1.7

1.9

38.7

39.0

u/l

0.17

687

4860

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1055

8017

1.34

17.12

2.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

651

4571

1.44

17.04

2.1

2.2

38.6

37.3

g/l

6.41

545

3856

(3025941) Bacteria identified in Stool by Culture

982

7413

1.34

16.66

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

963

7267

1.35

16.38

4.1

3.4

25.4

25.2

mmol/l

1.58

925

7047

(3002385) Erythrocyte distribution width [Ratio]

11481

109401

1.16

16.33

23.2

19.0

13.7

13.8

3.94

11266

106953

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

349

2.62

16.29

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

176

892

1.98

16.24

1.7

2.1

18.7

17.3

nmol/l

1.47

169

829

(3009508) Creatinine [Moles/volume] in Urine

4982

44772

1.16

16.24

3.2

7.3

mmol/l

0.13

4119

37095

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1642

13314

1.26

16.22

3.0

200.9

223.9

ng/l

1.51

1486

12184

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13867

134192

1.20

16.08

5.4

5.1

2.6

2.7

mmol/l

15.63

12642

122198

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

582

4058

1.45

15.83

2.2

2.4

0.0

g/l

0.50

525

3648

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

574

3993

1.45

15.81

2.2

2.4

0.0

g/l

0.00

522

3636

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

669

4790

1.41

15.73

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

205

1111

1.86

15.50

1.7

—

(3042517) Benzodiazepines panel - Urine

4.80

15.38

2.6

2.4

—

(3047181) Lactate [Moles/volume] in Blood

642

4602

1.41

15.01

5.2

6.0

1.2

1.3

mmol/l

1.73

574

4054

(3023323) Follitropin [Units/volume] in Serum or Plasma

593

4196

1.43

14.92

1.4

1.3

27.4

31.0

iu/l

1.74

508

3591

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

372

2.48

14.81

1.1

1.3

24.5

23.4

—

(3052851) Hemolysis interference index of Serum or Plasma

625

4481

1.41

14.60

3.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

483

3314

1.47

14.32

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4168

37301

1.16

13.92

2.6

2.7

3856.4

5197.7

umol/l

1.45

3493

31852

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

109

490

2.23

13.84

1.1

2251.4

468.4

ng/l

0.40

120

(3017732) Neutrophils [#/volume] in Blood

1176

9340

1.28

13.76

3.4

3.0

4.1

e9/l

0.06

836

6957

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

811

6124

1.34

13.75

2.0

1.9

1.8

2.2

ug/l

0.53

687

5387

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

765

5749

1.35

13.40

2.0

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

453

3112

1.47

13.37

1.3

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

446

3059

1.47

13.28

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

660

4855

1.37

13.26

2.0

1.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

432

2946

1.48

13.24

1.9

1.7

42.0

43.5

nmol/l

0.74

418

2827

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

462

3193

1.46

13.23

1.1

5.7

8.8

u/ml

0.80

339

(46235355) HIV 1 and 2 tests - Meaningful Use set

2130

18116

1.20

13.15

1.8

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

327

2110

1.56

13.01

2.0

1.9

182.5

195.8

pmol/l

1.46

310

1956

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

157

831

1.90

12.86

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

487

3419

1.44

12.84

2.2

2.3

129.2

127.8

g/l

0.66

367

2436

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

337

2.44

12.82

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

818

6253

1.32

12.76

2.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1603

13308

1.23

12.66

5.8

7.0

9.7

10.5

mmol/l

4.65

1499

12585

(3020191) Ethanol [Moles/volume] in Serum or Plasma

174

957

1.83

12.65

1.5

1.4

1.1

1.3

promille

0.92

137

729

(3008295) Osmolality of Serum or Plasma

237

1427

1.67

12.54

1.6

1.4

283.7

278.0

mosm/kgh2o

2.86

172

1086

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

382

2573

1.50

12.48

1.2

53.2

45.5

u/ml

0.36

265

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

126

625

2.02

12.47

2.9

2.6

16.4

32.6

ug/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

336

2.42

12.42

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1612

13426

1.22

12.33

2.1

2.2

0.2

g/l

3.46

1487

12432

(3035637) Corticotropin [Mass/volume] in Plasma

262

1628

1.62

12.26

1.4

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

339

2.40

12.19

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

529

3806

1.40

12.18

1.9

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1488

12311

1.23

12.14

3.6

3.9

1.2

mmol/l

0.26

1268

10672

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2228

19160

1.19

12.10

1.5

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

311

2.45

12.02

1.1

—

(3000492) Spirometry study

1438

11876

1.23

11.93

1.5

—

(3045414) Leukocytes [Presence] in Urine

811

6254

1.31

11.90

2.0

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1126

9059

1.26

11.83

2.3

1.9

—

(1761868) Lipid panel - Serum or Plasma

3866

42812

0.87

11.68

3.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

685

8980

0.75

11.66

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

334

2.37

11.65

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

152

824

1.85

11.62

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5146

47167

1.13

11.61

5.0

5.3

3.4

3.7

ug/l

0.23

4550

41923

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1115

8990

1.26

11.50

2.5

2.1

12.3

12.0

nmol/l

0.57

963

7830

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1020

8141

1.27

11.47

2.2

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

368

2.29

11.43

1.4

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

100

472

2.13

11.34

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

449

2.14

11.15

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

529

3868

1.38

11.09

2.8

3.1

25.4

24.8

mmol/l

2.49

473

3383

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

985

7864

1.27

11.05

6.9

8.7

24.6

24.3

mmol/l

1.84

899

7289

(3009214) Lutropin [Units/volume] in Serum or Plasma

400

2787

1.45

11.05

1.4

10.2

11.0

u/l

0.57

324

2245

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

295

1933

1.54

11.03

1.4

1.3

0.6

0.2

nmol/l

2.88

132

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2019

17352

1.19

10.99

3.1

4.1

234.2

246.7

u/l

3.89

1855

16330

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

465

2.11

10.98

2.6

2.9

25.7

28.6

umol/l

1.42

350

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13499

131208

1.15

10.98

4.7

4.6

4.5

4.6

mmol/l

24.11

12353

120034

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

7.28

10.97

1.6

217.9

239.9

nmol/l

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

904

7151

1.28

10.94

1.6

1.5

1.6

g/l

0.21

749

6089

(3003338) MCHC [Mass/volume]

11469

110334

1.13

10.93

26.4

20.3

331.5

331.8

g/l

2.94

11361

109388

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

497

3612

1.39

10.82

1.3

1.2

39.4

44.7

u/ml

0.16

223

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4139

37553

1.14

10.82

4.5

4.6

22.2

22.1

0.04

2019

19339

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13385

130067

1.15

10.75

4.7

4.5

1.4

1.5

mmol/l

12.21

12161

118257

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

291

1915

1.53

10.69

2.0

2.1

20.3

26.0

mg/l

1.18

508

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

210

2.67

10.63

1.1

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

472

3418

1.39

10.51

3.2

3.1

8.1

8.0

kpa

0.82

448

3162

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12959

125730

1.14

10.39

4.2

4.1

1.3

mmol/l

0.75

11659

113384

(3028717) Thiamine [Mass/volume] in Blood

132

3.11

10.25

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

6.67

10.17

1.4

1.6

167.5

223.6

nmol/l

0.50

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

290

1931

1.51

10.11

1.4

1.3

0.6

2.1

nmol/l

1.12

278

1852

(3021901) Oxygen saturation in Capillary blood

395

2803

1.42

9.92

2.8

2.9

—

(3003181) Sodium [Moles/volume] in Urine

379

2670

1.43

9.91

1.4

64.5

62.8

mmol/l

0.37

300

2125

(4024509)

226

1430

1.59

9.91

1.7

1.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

135

3.04

9.89

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

259

1698

1.53

9.73

14.4

11.0

7.4

7.5

mmol/l

0.13

215

1402

(40757494) Bilirubin.total [Moles/volume] in Blood

141

792

1.79

9.69

2.4

2.1

12.5

29.3

umol/l

1.80

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

5.87

9.58

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.62

9.51

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

521

3898

1.35

9.50

1.7

3.2

3.6

mg/l

0.54

412

2750

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1743

14974

1.18

9.48

4.1

3.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

267

1773

1.51

9.46

1.3

—

(3017509) Phencyclidine [Presence] in Urine

3.58

9.35

2.1

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

788

6252

1.27

9.34

4.7

5.0

1.6

0.06

734

5856

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

386

2761

1.41

9.30

2.4

2.1

5178.9

4660.9

u/l

0.12

126

1074

(3010421) pH of Blood

525

3947

1.34

9.28

4.0

7.4

0.27

435

3375

(3009445) Proteinase 3 Ab [Units/volume] in Serum

783

6216

1.27

9.24

1.4

1.5

29.2

14.5

u/ml

0.71

160

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

130

3.00

9.23

1.1

—

(3039000) Anion gap in Blood

450

3310

1.37

9.17

5.8

6.9

10.9

11.3

mmol/l

1.33

404

2969

(3018572) Chloride [Moles/volume] in Blood

450

3311

1.37

9.15

5.8

6.9

105.2

105.0

mmol/l

0.30

404

2970

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1072

8835

1.23

9.08

5.8

6.8

25.2

24.8

mmol/l

3.40

1059

8752

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

3.58

9.08

1.0

1.6

42.8

34.4

0.39

(3007930) Methemoglobin/Hemoglobin.total in Blood

774

6167

1.27

8.88

4.8

5.1

0.9

0.43

722

5777

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

452

3357

1.36

8.69

1.3

5.9

6.0

u/ml

0.02

541

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

106

565

1.88

8.67

3.0

1.8

139.5

122.0

umol/l

0.24

301

(3022621) pH of Urine by Test strip

1127

9383

1.22

8.64

3.8

3.1

—

(3022145) Colonoscopy Study observation

1782

15461

1.17

8.58

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

435

3227

1.36

8.43

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

971

7992

1.23

8.35

7.6

9.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

128

732

1.75

8.34

1.3

1.2

298.9

357.1

u/l

0.25

118

671

(40761536) Microorganisms panel - Urine sediment

1382

11766

1.19

8.34

5.2

4.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

317

2241

1.42

8.22

1.2

1.4

—

(3008898) HLA-B27 [Presence]

470

3545

1.34

8.18

1.1

—

(3049717) Cytology report of Urine Cyto stain

750

6014

1.26

8.18

2.4

2.8

—

(1616796) Gas panel - Central venous blood

450

3374

1.34

8.15

3.7

—

(3012516) Albumin [Mass/volume] in Urine

4652

43077

1.11

8.13

3.2

3.3

581.5

412.6

mg/l

1.21

2950

27087

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

442

3317

1.34

7.97

1.3

12.2

4.8

u/ml

0.60

356

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

3.58

7.83

1.0

1.6

6.1

14.6

1.90

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

250

1718

1.46

7.58

1.1

7.3

12.6

au/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

300

2134

1.41

7.55

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

205

2.39

7.54

1.3

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

12276

119369

1.11

7.50

21.4

16.9

39.1

39.2

0.51

7862

80621

(4035726)

1093

12895

0.84

7.30

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1318

11306

1.18

7.29

2.7

2.8

65.3

62.7

ml/min/173m2

1.64

541

4661

(3024928) Oxygen saturation in Venous blood

404

3034

1.34

7.29

2.7

3.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

259

1807

1.44

7.27

1.9

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

261

1828

1.43

7.18

1.1

40176.0

569.6

iu/ml

0.48

407

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

457

1.89

7.18

1.4

13.9

16.2

pmol/l

3.61

375

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

157

990

1.59

7.13

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

456

5886

0.77

7.02

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

410

3106

1.33

6.99

1.7

1.8

55.6

4.6

iu/l

0.80

121

1069

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

607

4841

1.26

6.99

1.5

1.6

124.5

271.0

titre

2.42

217

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.14

6.96

1.0

1.2

65.7

44.6

mg/l

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

4.36

6.95

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

3.29

6.94

1.2

1.4

—

13114.8

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

234

1619

1.45

6.89

1.3

1.2

31.1

58.7

u/ml

1.34

120

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

211

1431

1.48

6.89

2.7

2.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

116

685

1.70

6.83

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.25

6.81

1.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

942

7898

1.20

6.76

1.9

1.5

1.4

g/l

0.67

845

7128

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

185

2.38

6.74

1.1

1.4

41.5

54.0

0.80

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

100

569

1.76

6.73

2.5

2.2

54.0

55.5

umol/l

0.18

456

(3027315) Oxygen [Partial pressure] in Blood

450

3474

1.30

6.72

4.1

8.6

8.5

kpa

0.31

437

3393

(3012501) Base excess in Blood by calculation

447

3453

1.30

6.65

4.1

2.7

2.6

mmol/l

0.17

327

2358

(3013290) Carbon dioxide [Partial pressure] in Blood

447

3455

1.30

6.62

4.1

5.1

5.0

kpa

3.58

435

3374

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

3.56

6.57

1.0

1.5

3.4

1.0

0.55

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.10

6.57

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

163

2.46

6.56

2.3

2.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

304

2.04

6.55

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

208

1422

1.47

6.55

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

157

1013

1.56

6.50

1.4

—

(3011985) Renin [Units/volume] in Plasma

256

1822

1.41

6.49

1.3

1.4

54.7

60.4

mu/l

0.23

223

1616

(3030981) Hyaline casts [#/volume] in Urine by Automated count

926

7783

1.20

6.49

3.1

2.8

0.3

e6/l

0.10

897

7615

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

242

1710

1.42

6.40

1.3

285.3

293.8

pmol/l

0.11

173

1304

(3035060) Mercury [Moles/volume] in Blood

6.67

6.31

1.6

2.0

10.9

10.4

nmol/l

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

288

2105

1.37

6.26

1.6

0.6

0.8

g/l

2.24

216

1573

(3036489) Thrombin time

609

4927

1.24

6.23

1.8

2.0

21.5

21.7

0.21

546

4347

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

561

1.73

6.20

1.7

1.6

5.2

4.2

nmol/l

0.19

467

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

367

2791

1.32

6.15

1.3

1.2

2.3

5.1

u/ml

1.13

211

(3019832) Treponema pallidum Ab [Presence] in Serum

908

7658

1.20

6.14

1.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

516

1.75

5.95

1.9

2.1

22.7

297.9

ug/l

1.36

487

(3020682) Albumin/Creatinine [Ratio] in Urine

4834

45393

1.09

5.95

3.9

4.0

8.2

9.6

mg/mmol

1.17

3029

28358

(40768804) Tissue Pathology biopsy report

5909

55985

1.09

5.88

2.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

258

1875

1.38

5.84

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

142

2.47

5.83

1.1

—

(3037121) Protein [Mass/volume] in Urine

618

5047

1.23

5.82

2.8

3.0

0.3

g/l

1.38

226

2100

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

366

2813

1.31

5.71

1.3

1.2

16.2

12.9

u/ml

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

117

728

1.61

5.71

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

117

728

1.61

5.71

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

639

5249

1.23

5.70

2.6

2.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

107

653

1.64

5.65

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

533

1.71

5.61

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

176

2.28

5.59

2.3

2.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

252

1841

1.37

5.55

1.4

—

(3044927) Protein electrophoresis panel - Urine

222

1589

1.40

5.52

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

250

1827

1.37

5.50

1.4

—

(3007463) Buprenorphine [Presence] in Urine

4.80

5.49

2.7

8.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

153

1023

1.50

5.46

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

201

1425

1.42

5.30

1.3

1.4

31.0

29.9

u/l

0.17

159

1165

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

227

1644

1.39

5.29

1.1

—

(4062490)

188

1319

1.43

5.26

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

247

1819

1.36

5.20

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

247

1820

1.36

5.18

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.88

5.18

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

247

1823

1.36

5.13

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.79

5.12

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.72

5.09

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1951

17639

1.12

5.08

4.9

4.7

33.2

32.8

0.82

1334

11733

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

131

862

1.52

5.07

1.3

0.9

1.5

u/ml

0.63

422

(3045424) Erythrocytes [Presence] in Urine

307

2345

1.31

5.07

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

163

1126

1.45

4.98

1.6

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

187

1327

1.41

4.94

1.5

1.4

6.5

6.9

g/l

0.64

127

910

(3024139) IgG subclass 3 [Mass/volume] in Serum

187

1327

1.41

4.94

1.5

1.4

0.4

g/l

1.52

128

914

(3047007) Chlamydophila sp Ab [Presence] in Serum

218

1589

1.38

4.92

1.3

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

187

1328

1.41

4.92

1.5

1.4

2.8

2.9

g/l

0.27

126

916

(40767503) Oxygen content in Capillary blood by calculation

407

3244

1.26

4.84

3.0

2.5

16.4

16.0

1.56

248

1663

(3025018) Bordetella pertussis Ab [Titer] in Serum

101

634

1.60

4.83

1.4

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1539

13764

1.13

4.82

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

404

3227

1.26

4.73

2.4

2.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

444

3589

1.24

4.68

1.8

2.0

10.8

11.7

mg/l

1.40

410

3318

(3019977) pH of Arterial blood

129

863

1.50

4.66

2.5

2.6

7.4

0.65

319

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

105

673

1.56

4.61

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

103

2.53

4.61

1.0

1.1

16.6

11.9

u/l

0.28

103

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

288

1.88

4.61

1.1

1.2

0.6

63.7

mg/l

1.45

215

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

205

1504

1.37

4.48

1.1

2.5

3.6

u/ml

0.91

627

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

106

687

1.55

4.45

1.5

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

109

712

1.53

4.42

1.1

11.1

9.4

iu/ml

0.09

167

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

458

3742

1.23

4.40

1.9

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

466

1.66

4.30

1.2

1.3

4.3

3.9

umol/l

0.42

434

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

437

3571

1.23

4.21

1.5

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

429

3505

1.23

4.15

1.7

1.6

13023.2

14992.6

e6/l

0.48

320

2509

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

390

3156

1.24

4.12

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

122

2.30

4.09

1.3

16.5

18.5

pmol/l

0.12

108

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

199

1479

1.35

4.05

4.0

3.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

586

4949

1.19

4.03

2.3

3.3

14.3

3.3

ratio

0.43

372

(3017181) Myelocytes/100 leukocytes in Blood

1341

12031

1.12

4.02

3.7

4.0

0.9

0.01

346

3549

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

369

1.71

4.00

1.2

107.6

113.3

1.07

318

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

245

1881

1.31

3.99

1.1

1.3

u/ml

0.22

736

(3016038) Potassium [Moles/volume] in Urine

140

986

1.42

3.95

1.2

32.4

34.7

mmol/l

0.66

120

828

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

588

1.55

3.92

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

177

1299

1.37

3.92

1.1

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

357

1.71

3.90

1.0

1.2

—

(4281824)

109

1589

0.68

3.85

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

1274

11427

1.12

3.84

3.7

4.0

0.2

0.1

0.71

315

3290

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

294

2325

1.27

3.83

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

598

5085

1.18

3.82

2.3

3.3

31.7

47.7

mg/l

4.66

484

4086

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

390

1.67

3.80

1.2

0.3

g/l

0.19

311

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

180

2.00

3.76

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

287

1.78

3.74

1.1

—

(3003577) Lead [Moles/volume] in Blood

2.64

3.72

1.1

1.3

0.1

0.2

umol/l

—

(3025159) Blasts/100 leukocytes in Blood

1196

10712

1.13

3.70

3.8

4.0

0.4

0.3

0.10

264

2785

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

348

1.70

3.69

1.7

1.6

0.4

ug/l

0.21

218

(3034860) Kappa light chains.free [Mass/volume] in Serum

597

5094

1.18

3.68

2.3

3.3

55.8

69.0

mg/l

0.45

484

4088

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3784

35782

1.07

3.64

1.6

1.4

1.3

mmol/l

0.33

3167

29661

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

183

1.97

3.61

1.3

1.6

—

(4094501)

429

3561

1.21

3.60

1.1

—

(3023419) Bacteria identified in Sputum by Culture

243

1895

1.29

3.57

2.5

2.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

179

1339

1.34

3.55

1.5

1.4

28.7

28.9

iu/ml

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

351

2861

1.23

3.53

1.2

180.0

153.2

titre

—

(3051611) Lipemic interference index of Serum or Plasma

209

1600

1.31

3.53

3.6

3.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

278

1.76

3.52

1.4

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

303

2433

1.25

3.50

2.8

2.9

63.7

63.5

0.07

303

2422

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

477

4011

1.19

3.50

1.4

1.5

22.9

14.7

iu/ml

0.42

(3026389) Candida sp identified in Specimen by Organism specific culture

258

2034

1.27

3.48

1.4

—

(3020491) Glucose [Moles/volume] in Blood

138

994

1.39

3.48

2.1

1.9

7.1

7.0

mmol/l

0.21

682

(3013005) Retinol [Moles/volume] in Serum or Plasma

494

1.56

3.47

1.4

1.8

1.7

2.0

umol/l

2.52

461

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

187

1.93

3.41

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

132

947

1.40

3.41

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

132

947

1.40

3.41

1.1

—

(4146454)

212

1635

1.30

3.41

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

167

1247

1.34

3.37

2.2

2.1

2.2

2.1

u/field

0.03

496

(3017143) Hepatitis C virus Ab [Presence] in Serum

1441

13114

1.11

3.37

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.00

3.36

1.1

3.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

5.00

3.36

1.7

1.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

147

2.04

3.34

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

132

951

1.39

3.34

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

132

953

1.39

3.30

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

131

946

1.39

3.27

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

176

1.93

3.27

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

315

1.68

3.26

2.9

2.1

198.9

757.7

e6/l

1.23

163

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.02

3.24

1.7

1.3

498.5

487.6

nmol/l

0.02

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

184

1.90

3.22

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

460

3888

1.19

3.22

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

131

951

1.38

3.18

1.1

—

(3036180) Methadone [Presence] in Urine

6.37

3.18

2.0

3.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

265

2122

1.25

3.18

1.1

1.2

—

(3006270) Folate [Moles/volume] in Blood

169

1278

1.33

3.16

1.2

332.5

342.8

nmol/l

0.29

136

1035

(3038177) Helicobacter pylori Ab [Presence] in Serum

250

1991

1.26

3.15

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

316

2592

1.22

3.05

1.7

0.8

nmol/l

0.74

250

2160

(3052592) Norovirus Ag [Presence] in Stool

314

1.66

3.04

1.3

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

617

1.46

3.02

1.2

1.5

26.6

23.9

umol/l

0.34

586

(3035947) Staphylolysin Ab [Units/volume] in Serum

675

1.44

3.02

1.1

2.8

3.7

iu/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

214

1684

1.27

2.99

1.1

5.2

4.9

u/ml

0.08

823

(3028271) Lactate [Moles/volume] in Capillary blood

298

2436

1.23

2.99

2.2

1.9

1.7

mmol/l

0.10

290

2380

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

465

1.53

2.98

1.5

599437.7

1555193.0

iu/ml

—

(3051651) Icteric interference index of Serum or Plasma

123

895

1.38

2.98

3.4

3.7

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.00

2.96

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.40

2.96

1.2

1.1

34.3

49.2

u/l

1.11

(3017569) Oxygen content in Arterial blood

103

730

1.41

2.91

2.3

2.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.32

2.90

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

582

1.46

2.89

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

1028

0.67

2.84

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

610

1.44

2.82

1.2

1.6

6.6

9.0

ug/l

1.53

547

(40768800) Prostate Pathology biopsy report

251

3089

0.81

2.81

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

456

1.52

2.80

2.2

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

456

1.52

2.80

2.2

2.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

338

1.60

2.77

1.4

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

191

1499

1.28

2.76

1.1

2.1

1.9

u/ml

0.11

341

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

119

874

1.36

2.75

2.7

2.4

481.7

513.8

e6/l

0.39

102

723

(3002179) Metamyelocytes/100 leukocytes in Blood

1196

10904

1.10

2.75

3.5

3.9

0.6

0.7

0.47

232

2565

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

124

2.02

2.75

1.6

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

246

1991

1.24

2.74

5.6

6.4

12.1

11.9

mg/l

0.25

218

1803

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.31

2.74

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

305

2536

1.21

2.63

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

178

1396

1.28

2.61

1.3

1.4

133198.3

151077.5

e6/l

0.13

123

952

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

269

2213

1.22

2.59

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

406

3468

1.17

2.58

1.5

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

415

3556

1.17

2.55

1.2

154.1

143.5

titre

0.08

301

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

268

2208

1.22

2.55

1.4

116.6

117.4

u/ml

0.04

481

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

113

836

1.35

2.52

2.8

2.5

0.2

e9/l

0.12

103

721

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

175

1377

1.27

2.52

1.4

0.3

0.4

nmol/l

1.99

143

1017

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

363

1.54

2.51

1.1

1.2

83.6

86.3

0.23

176

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

416

3570

1.17

2.51

2.2

2.4

92.6

106.3

ug/min

0.40

234

2098

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

314

2631

1.20

2.51

2.6

3.1

—

(40768793) Breast Pathology biopsy report

245

2982

0.82

2.51

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

115

2.00

2.50

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

194

1.75

2.49

3.0

2.7

0.7

0.5

u/field

0.35

194

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

372

1.53

2.49

1.1

89.6

86.5

0.30

174

(44806118)

191

1522

1.26

2.48

1.3

1.5

—

(44790048)

191

1522

1.26

2.48

1.3

1.5

—

(44790049)

191

1522

1.26

2.48

1.3

1.5

—

(44790047)

191

1522

1.26

2.48

1.3

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.11

2.48

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

117

874

1.34

2.46

1.7

1.9

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

295

1.59

2.43

1.3

1.1

0.7

0.6

umol/24h

0.49

130

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

186

1484

1.26

2.40

1.4

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

131

1.91

2.39

1.2

1.1

1.6

umol/24h

0.05

131

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

250

1.64

2.38

1.1

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

283

2362

1.20

2.38

1.2

—

(44813793)

114

854

1.34

2.37

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2826

26838

1.06

2.34

3.1

3.2

0.7

0.8

ug/l

1.94

2005

18760

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

140

1.86

2.31

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.31

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

268

2236

1.20

2.28

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

401

3462

1.16

2.28

1.4

1.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

323

2741

1.18

2.27

2.6

3.3

4.1

4.2

e9/l

0.25

323

2735

(37021550) Renin [Units/volume] in Plasma --upright

293

1.57

2.26

1.2

69.5

83.2

mu/l

0.20

212

(3034274) Bile acid [Moles/volume] in Serum --fasting

139

1082

1.29

2.22

1.7

2.0

8.8

8.5

umol/l

0.07

794

(3024263) Appearance of Synovial fluid

736

1.35

2.19

1.8

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

109

1428

0.76

2.15

1.4

1.5

—

(3028433) Virus identified in Specimen by Culture

468

1.43

2.15

1.3

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

253

3015

0.84

2.13

1.3

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

199

1626

1.23

2.12

1.1

0.8

1.1

u/ml

0.34

666

(40760888) Immunoglobulin light chains.free panel - Serum

440

3851

1.15

2.10

2.2

3.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

259

2176

1.19

2.07

1.2

314.6

281.4

u/ml

0.68

155

1359

(3013166) Neutrophils/100 leukocytes in Synovial fluid

455

1.43

2.07

1.3

57.8

57.4

0.03

383

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

153

1.77

2.07

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

239

1994

1.20

2.07

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

132

1032

1.28

2.06

1.3

12.6

11.7

mmol/l

0.35

299

(3028679) Herpes simplex virus Ab [Presence] in Serum

548

1.39

2.05

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

130

1016

1.28

2.04

3.7

2.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

121

1550

0.78

2.03

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

121

1549

0.78

2.02

1.3

1.4

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.63

2.00

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

149

1189

1.26

1.98

4.2

4.9

154.5

94.2

u/ml

0.46

347

(3005033) Fetal Nuchal fold Thickness US

1262

0.76

1.97

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

122

1554

0.78

1.97

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

361

1.47

1.96

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

122

1553

0.78

1.96

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

743

1.32

1.94

1.9

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.96

1.93

1.3

1.1

1.5

2.9

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

3.75

1.93

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.73

1.93

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

106

814

1.30

1.92

2.0

1.9

1.7

2.8

u/field

1.25

574

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1268

0.76

1.92

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

101

1313

0.77

1.92

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

384

3354

1.15

1.92

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

711

1.32

1.90

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

711

1.32

1.90

1.7

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

159

1286

1.24

1.90

1.1

1.0

4.3

3.7

u/ml

0.14

488

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

134

1678

0.80

1.88

1.4

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1048

0.74

1.88

1.3

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

158

1.71

1.88

1.5

1.4

0.3

0.2

nmol/l

0.17

109

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.18

1.88

1.1

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

155

1253

1.24

1.86

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

155

1253

1.24

1.86

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

155

1253

1.24

1.86

1.4

1.6

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.08

1.86

1.2

—

2.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

149

1200

1.24

1.86

1.1

1.0

5.2

3.5

u/ml

0.38

462

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

288

2471

1.17

1.84

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.53

1.83

2.7

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

253

1.54

1.83

1.2

69.5

71.1

0.12

(3034770) Mitochondria Ab [Titer] in Serum

405

3565

1.14

1.82

1.1

1.2

637.8

890.3

titre

—

112

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

108

1.85

1.81

1.3

0.9

ml/s/173m2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

145

1.73

1.80

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

241

2042

1.18

1.80

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.92

1.79

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

215

1.58

1.78

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1519

16150

0.93

1.77

3.2

4.0

12.0

23.7

ug/l

2.15

1209

13256

(3010370) Gastrin [Moles/volume] in Serum or Plasma

216

1.58

1.75

1.5

1.7

28.8

51.4

pmol/l

1.61

178

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1272

0.78

1.75

3.5

3.0

13.1

13.2

0.42

1251

(3003694) ABO and Rh group [Type] in Blood

3669

35371

1.05

1.75

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

165

1354

1.22

1.75

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

557

1.35

1.74

3.1

2.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

481

1.37

1.73

1.2

1.1

1692.2

1538.0

miu/ml

0.50

481

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

208

1749

1.19

1.71

1.1

1.5

g/l

1.06

180

1576

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

103

1.85

1.71

1.6

1.2

22.1

mmol/l

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

238

2026

1.18

1.70

1.5

1.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

373

1.42

1.70

3.9

5.3

69.5

70.6

0.10

296

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.00

1.69

1.6

0.9

1.8

mg/l

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

439

3908

1.13

1.68

2.1

2.5

3.5

3.6

g/l

0.76

413

3710

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

175

1451

1.21

1.68

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

238

2029

1.18

1.68

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

126

1010

1.25

1.67

1.3

746.5

424.5

titre

0.36

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

211

1.57

1.67

1.3

1.2

174.5

530.6

ng/l

0.44

140

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

167

1380

1.21

1.66

1.4

1.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

270

2327

1.16

1.66

1.2

—

(3037756) Immunofixation for Serum or Plasma

382

3374

1.14

1.66

1.4

1.6

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.80

1.65

1.1

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.97

1.64

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

122

978

1.25

1.62

1.3

111.7

59.9

titre

—

(3016330) Potassium [Moles/time] in 24 hour Urine

181

1.60

1.62

1.4

1.2

—

85.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

326

2856

1.14

1.62

1.6

—

(40768806) Pleura Pathology biopsy report

144

1754

0.82

1.61

1.6

1.5

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.57

1.61

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

670

1.30

1.60

1.3

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

254

1.50

1.59

1.1

1.2

90.6

77.4

0.86

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

549

1.33

1.59

1.1

2.7

6.6

u/ml

1.97

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

619

1.31

1.58

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

370

3275

1.13

1.58

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

760

1.28

1.57

1.1

18.6

26.9

u/l

1.67

572

(3004451) EKG impression Narrative

769

1.28

1.57

1.3

—

(40768795) Lymph node Pathology biopsy report

115

1429

0.80

1.57

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

188

1582

1.19

1.57

1.2

61.6

61.9

u/l

0.02

114

1054

(3017817) Protein [Mass] in Urine collected for unspecified duration

161

1336

1.21

1.56

2.0

2.4

—

0.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

551

1.33

1.56

1.2

1.1

9.1

17.8

u/ml

—

(1175426) CD3 cells/100 lymphocytes in Blood

126

1020

1.24

1.55

2.4

2.0

73.4

71.7

0.74

121

969

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

762

1.27

1.54

1.1

73.5

88.8

u/l

1.85

595

(3012494) Peanut IgE Ab [Units/volume] in Serum

289

1.45

1.54

1.0

1.1

1.2

5.3

u/ml

0.69

149

(3051593) INR in Capillary blood by Coagulation assay

781

1.27

1.53

8.5

11.1

—

(3033799) Differential panel - Peritoneal fluid

469

0.66

1.53

2.7

1.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

331

1.42

1.53

1.1

1.2

587.1

308.3

pmol/l

0.34

237

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1653

15669

1.06

1.51

1.6

—

(3018291) Platelet Ab [Presence] in Serum

2.86

1.50

1.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

526

0.68

1.49

2.2

2.0

440.1

3381.5

e6/l

1.02

363

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

713

1.28

1.49

2.2

3.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

392

1.38

1.49

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

123

999

1.23

1.48

2.4

2.0

14.7

0.00

418

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.95

1.48

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

206

1758

1.17

1.48

1.3

1.2

3.7

4.1

u/ml

0.24

779

(3026692) Albumin [Mass/volume] in Peritoneal fluid

380

0.63

1.47

1.3

1.5

12.8

13.9

g/l

0.19

292

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

255

0.55

1.46

3.7

2.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

136

1645

0.83

1.45

1.3

1.2

7.3

7.6

mmol/l

0.49

1185

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

629

1.29

1.43

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

141

1167

1.21

1.43

1.6

32.3

24.4

u/ml

0.97

240

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.31

1.42

1.0

—

(3045142) Bone marrow Pathology biopsy report

136

1638

0.83

1.40

1.2

1.3

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

157

1.59

1.40

1.1

103.0

79.7

ug/l

1.28

123

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

756

1.26

1.39

1.4

75.9

103.0

pmol/l

0.31

246

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.89

1.38

1.6

1.2

1.3

1.1

u/field

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

406

3652

1.11

1.36

2.2

2.5

184.0

197.9

2.43

386

3453

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

360

0.64

1.36

6.8

8.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

289

1.42

1.35

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

348

1.38

1.35

1.7

1.8

—

(3045716) Anion gap in Serum or Plasma

671

1.27

1.34

1.4

2.3

8.5

9.1

mmol/l

0.74

502

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

437

3952

1.11

1.33

1.9

2.2

91.8

90.1

0.84

412

3687

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

116

950

1.22

1.33

2.6

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

225

1957

1.15

1.30

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

196

1688

1.16

1.29

1.3

—

(3011412) CD3 cells [#/volume] in Blood

152

1282

1.19

1.29

2.6

2.3

1.1

e9/l

0.01

786

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1897

18141

1.05

1.29

1.5

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

306

0.62

1.28

6.8

8.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.05

1.26

1.0

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

208

1804

1.15

1.26

1.3

1.2

1.8

4.2

u/ml

4.01

597

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

265

2338

1.14

1.25

1.2

1.3

39.9

38.1

u/l

0.06

224

2008

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

337

1.37

1.24

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

337

1.37

1.24

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

337

1.37

1.24

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

337

1.37

1.24

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

164

1918

0.85

1.24

1.3

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

157

0.51

1.24

1.6

2.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

670

1.25

1.24

1.1

ratio

0.67

218

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

127

1059

1.20

1.23

1.1

1.0

0.1

0.4

u/ml

1.33

242

(3015076) Soybean IgE Ab [Units/volume] in Serum

485

1.30

1.23

1.1

1.0

0.4

1.3

u/ml

—

(3011897) Casein IgE Ab [Units/volume] in Serum

139

1.58

1.22

1.0

1.2

18.3

2.6

u/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

173

2012

0.86

1.22

1.7

1.6

—

(40768441) Liver Pathology biopsy report

997

0.80

1.19

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.11

1.18

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

114

947

1.21

1.17

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

370

0.68

1.17

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

569

1.27

1.16

1.1

10.6

1.7

u/ml

0.41

174

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

428

0.70

1.16

2.3

1.7

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.05

1.15

1.5

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

386

1.32

1.14

1.4

1.2

—

(3000285) Sodium [Moles/volume] in Blood

199

1.46

1.14

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

497

5401

0.92

1.13

2.6

3.4

933.1

1897.4

u/ml

0.73

411

4619

(3036071) Salmonella sp Ab [Titer] in Serum

370

1.33

1.12

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1064

0.82

1.11

1.3

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.76

1.06

9.0

4.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

396

0.71

1.05

1.4

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

241

0.62

1.04

4.8

7.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

668

0.78

1.03

1.1

—

(40757373) Influenza virus identified in Isolate

306

1.34

1.03

1.5

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

378

4134

0.91

1.02

6.3

4.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

371

3387

1.10

1.01

3.4

3.1

0.8

nmol/l

0.11

288

2607

(3000330) Specific gravity of Urine by Test strip

806

7587

1.07

1.01

4.4

3.7

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.00

1.00

1.3

1.2

—

mmol/l

—

(3044007) Cell count panel - Peritoneal fluid

414

0.72

0.99

3.1

1.9

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

133

1142

1.17

0.98

1.4

11.9

13.1

u/l

1.75

127

1096

(3027923) C peptide [Moles/volume] in Serum or Plasma

720

1.21

0.97

1.6

1.4

1.1

1.2

nmol/l

0.26

560

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

108

1273

0.85

0.96

1.6

1.7

—

(40758292) HTLV I+II Ab panel - Serum

199

0.60

0.96

1.3

1.4

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.74

0.96

1.1

—

3.6

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

0.00

0.95

0.0

1.4

—

0.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.69

0.95

1.0

0.0

0.7

u/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

141

1223

1.15

0.92

1.6

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

150

1.47

0.92

2.1

1.7

34.4

46.5

umol/l

1.98

150

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.71

0.92

1.1

—

(3021788) Differential panel - Synovial fluid

296

2689

1.10

0.92

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

184

1.41

0.91

4.2

5.4

50.1

48.2

ug/min

0.06

147

(3008536) Aspergillus sp Ab [Presence] in Serum

278

0.68

0.89

1.6

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

224

2010

1.12

0.88

3.0

2.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.69

0.88

1.5

1.4

445.9

303.5

umol/24h

1.17

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

160

1.44

0.88

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

427

0.75

0.87

1.3

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.61

0.87

1.7

1.5

0.6

0.7

umol/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

111

952

1.17

0.86

1.5

1.6

5.5

6.2

u/l

0.16

460

(3022689) Creatine [Moles/volume] in Urine

414

0.75

0.86

1.4

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

631

1.21

0.85

3.4

3.2

16.0

26.9

mu/l

3.79

592

(3051101) Glucose [Moles/volume] in Cord blood

275

0.69

0.85

3.9

6.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

170

1.41

0.84

1.8

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

894

8497

1.06

0.84

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.94

0.84

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

230

1.35

0.84

1.2

1.4

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.78

0.84

1.0

1.1

0.0

mg/l

—

(4015189)

425

1.25

0.83

2.1

2.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

301

1.30

0.82

1.8

1.5

112.5

118.4

ng/l

0.08

301

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

478

0.77

0.82

1.3

1.4

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

1.88

0.81

1.0

0.2

g/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.88

0.81

1.0

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

226

2041

1.11

0.81

2.9

2.4

4.1

mmol/l

0.03

226

2023

(3035285) Chloride [Moles/volume] in Venous blood

226

2041

1.11

0.81

2.9

2.4

106.0

105.6

mmol/l

0.52

226

2023

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

169

1502

1.13

0.81

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

105

903

1.16

0.80

1.9

1.6

60.6

71.4

umol/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

465

0.77

0.80

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

186

1664

1.12

0.80

1.1

118.0

117.2

0.13

177

1468

(3041918) Cholesterol [Moles/volume] in Pleural fluid

303

1.29

0.79

1.2

1.9

1.6

mmol/l

0.45

188

(3043410) Blood group antigens tested for on Red Blood Cells

392

1.25

0.79

1.4

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

124

1082

1.15

0.79

1.1

1.2

75.7

169.1

titre

2.96

200

(3022475) Manganese [Moles/volume] in Blood

1.62

0.78

1.0

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.56

0.78

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

650

0.81

0.77

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

155

1379

1.13

0.75

1.5

27.1

29.6

0.39

837

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

577

1.20

0.74

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.08

0.74

1.2

1.0

—

(3024471) HLA-A [Type]

381

0.76

0.74

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

468

1.22

0.74

1.2

1.1

—

(40768443) Skin Pathology biopsy report

682

6466

1.06

0.74

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

790

1.17

0.74

1.1

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

100

1.50

0.72

1.1

1.0

—

(3019174) dRVVT (LA screen)

100

1.50

0.72

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.80

0.72

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.61

0.72

1.0

1.1

9.3

8.3

mmol/l

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

202

1.34

0.72

1.1

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

570

5385

1.06

0.70

2.7

3.0

0.4

u/ml

0.91

328

3074

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

109

1.47

0.70

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

554

1.19

0.70

1.0

4.1

1.0

u/ml

0.43

143

(3003434) Protein [Mass/volume] in Pleural fluid

204

2244

0.91

0.70

1.4

1.5

32.8

32.2

g/l

0.29

183

1997

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

186

1.34

0.69

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

106

926

1.15

0.69

2.6

2.4

861.7

650.3

e6/l

1.80

373

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

239

1.30

0.68

1.7

3.2

132.9

140.5

ng/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.85

0.68

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.53

0.68

1.1

1.2

527.1

283.8

nmol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

853

1.15

0.67

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

788

1.16

0.67

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

736

0.84

0.67

1.6

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

484

1.20

0.66

1.1

93.9

94.6

0.07

367

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

183

1659

1.10

0.66

1.6

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

323

3471

0.93

0.65

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

133

1189

1.12

0.63

1.4

1.3

1.5

1.4

nmol/l

0.71

121

1072

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

124

1104

1.12

0.62

1.2

93.0

82.1

u/ml

—

(3012565) Volume of 24 hour Urine

738

1.15

0.62

1.9

2.2

2075.1

1887.4

0.80

641

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

138

1.38

0.62

1.3

—

(3012441) Differential panel - Pleural fluid

156

1725

0.90

0.62

1.5

—

(3002619) Bacteria identified in Specimen by Culture

297

1.25

0.62

1.4

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

268

0.75

0.61

5.1

4.9

43.3

65.1

u/l

—

(3001729) Color of Synovial fluid

130

1.38

0.61

1.3

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

139

0.65

0.60

7.1

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

139

0.65

0.60

3.6

2.9

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.60

0.0

2.8

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.60

0.0

1.1

—

1806.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

124

1108

1.12

0.60

1.2

38.7

35.6

u/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.50

0.59

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

103

911

1.13

0.59

1.3

1.2

78.0

89.8

u/l

0.81

783

(3014891) Appearance of Pleural fluid

237

1.27

0.58

1.3

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

391

1.20

0.57

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

149

1.34

0.57

1.1

1.0

—

(44806071)

149

1.34

0.57

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

419

1.19

0.57

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

698

1.15

0.56

1.5

3.6

2.15

159

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

100

886

1.13

0.56

1.3

1.2

22.3

24.5

u/l

0.15

745

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

549

1.17

0.56

2.3

2.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

186

1705

1.09

0.56

3.1

3.4

6.2

10.8

nmol/l

0.64

177

1657

(4212803)

141

1.35

0.56

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

164

1495

1.10

0.56

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

973

1.12

0.55

1.6

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

142

1.34

0.54

1.2

—

(4268621)

132

1193

1.11

0.54

2.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

275

2570

1.07

0.53

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

322

1.21

0.53

1.1

—

(3036603) Volume of Urine

108

967

1.12

0.53

1.4

1.6

1846.6

1962.9

0.26

247

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

178

1.29

0.52

5.1

5.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

107

958

1.12

0.52

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

271

0.77

0.52

1.0

1.8

1.9

2.4

ug/l

—

151

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.62

0.52

4.2

4.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.62

0.52

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

390

3690

1.06

0.51

1.4

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

297

3164

0.94

0.51

2.5

3.4

418.8

707.4

u/ml

0.66

273

2875

(3024932) HLA-DR beta [Type]

370

0.81

0.51

1.1

—

(4306422)

187

1725

1.08

0.51

1.2

—

(44806420)

455

0.83

0.49

2.3

2.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.43

0.49

1.1

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

459

4372

1.05

0.48

1.9

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

266

2834

0.94

0.48

1.4

1.5

112.7

180.9

pmol/l

3.29

258

2756

(3002523) Influenza virus A Ag [Presence] in Specimen

162

1491

1.09

0.48

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

137

1.31

0.47

1.1

1.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

332

0.81

0.46

1.9

1.4

32.8

26.0

g/l

1.22

258

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

103

1.36

0.45

1.1

1.6

—

(3017704) Immunofixation for Urine

856

1.11

0.44

1.2

1.6

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.37

0.44

1.1

1.2

6.9

0.9

u/ml

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

459

0.85

0.43

2.0

1.9

20537.3

13300.0

e6/l

0.20

249

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

130

1.31

0.43

2.5

5.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

522

5006

1.04

0.43

1.8

1.7

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

293

1.19

0.43

2.4

2.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

330

1.18

0.43

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

284

1.20

0.43

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

353

3714

0.95

0.43

3.3

3.2

1.6

mg/l

0.46

322

3360

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

104

1145

0.91

0.43

1.1

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

766

0.89

0.42

2.2

100.6

139.7

ug/min

0.21

181

(3011648) Oxygen content in Venous blood

119

1088

1.09

0.42

1.8

2.5

11.1

10.8

0.25

119

1088

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

109

1194

0.91

0.41

2.1

2.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.38

0.41

1.1

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.41

0.0

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

177

1649

1.07

0.41

2.7

3.9

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.36

0.41

1.4

1.6

—

(3025130) Human papilloma virus identified in Specimen

150

1389

1.08

0.41

1.9

1.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.40

0.0

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.47

0.40

5.0

9.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

150

1.27

0.40

4.2

2.7

8.0

7.5

mmol/l

0.19

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

249

0.80

0.40

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

327

3111

1.05

0.39

4.8

3.5

25.5

28.8

mg/l

0.95

195

2007

(3042951) Complement C1q Ab [Units/volume] in Serum

1.31

0.39

1.0

1.1

—

20.7

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

10.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

204

0.78

0.39

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

186

1742

1.07

0.38

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.36

0.38

1.2

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

410

1.15

0.38

1.0

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

170

0.76

0.38

1.1

1.2

142.1

106.5

ug/l

—

110

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

113

1039

1.09

0.37

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

161

1.24

0.37

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

318

1.16

0.36

2.0

2.4

7.4

7.8

mmol/l

0.22

201

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

657

6784

0.97

0.36

2.7

3.7

58.7

68.3

u/ml

0.31

622

6530

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

135

0.74

0.36

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.33

0.35

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

144

1.25

0.35

2.2

2.5

0.3

1.3

mmol/l

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

255

0.82

0.35

1.6

1.4

6.3

11.5

1.05

134

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

144

0.76

0.33

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

164

1.22

0.32

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

407

3919

1.04

0.32

1.6

0.4

9.3

iu/ml

1.41

112

900

(3035611) Eosinophils/100 leukocytes in Synovial fluid

110

1.27

0.31

1.4

1.6

0.8

0.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

188

1985

0.95

0.30

1.4

1.5

3465.0

2548.8

e6/l

0.46

140

1430

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

184

1.20

0.30

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

184

1.20

0.30

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

184

1.20

0.30

1.4

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

268

1.16

0.30

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

173

1636

1.06

0.29

1.5

2.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

141

1498

0.94

0.29

1.3

1.4

5.9

6.3

mmol/l

1.21

130

1371

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.23

0.29

1.0

0.0

2.7

u/ml

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

852

1.08

0.28

1.7

1.5

—

(3042631) Mycobacterium sp identified in Specimen

206

2163

0.95

0.28

2.6

2.7

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.32

0.28

1.3

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.32

0.28

1.5

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

393

1.12

0.28

3.0

2.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

194

0.82

0.27

2.1

2.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

142

1340

1.06

0.27

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

469

0.90

0.27

2.2

1.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

203

0.84

0.25

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

848

1.07

0.25

1.7

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

403

0.89

0.24

1.3

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

134

1269

1.06

0.24

1.1

95.8

94.9

0.18

129

1171

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

389

1.11

0.23

1.5

1.8

—

(40768446) Kidney Pathology biopsy report

495

1.09

0.23

1.7

1.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

168

0.83

0.22

1.2

1.5

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

689

1.07

0.22

2.6

2.5

208.4

208.5

u/l

0.00

682

(21494434) Karyotype in Bone marrow

122

1286

0.95

0.22

1.1

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

267

1.12

0.21

1.3

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.21

0.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.21

0.0

1.9

—

10.4

—

(3000034) Microalbumin [Mass/volume] in Urine

129

1356

0.95

0.21

2.9

3.0

26.7

46.3

mg/l

1.19

982

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

114

1202

0.95

0.21

2.0

1.8

3.6

4.2

mg/l

1.21

106

1133

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

126

1.19

0.21

1.1

—

(3020650) Glucose [Presence] in Urine

325

1.11

0.21

1.3

1.4

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

173

1804

0.96

0.20

1.4

1.5

83370.4

59037.7

e6/l

0.42

101

1065

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

134

0.82

0.20

4.6

2.6

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

145

1.17

0.20

1.1

1.0

0.3

6.3

u/ml

0.91

107

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

297

2880

1.03

0.20

1.3

247.4

221.3

miu/ml

0.54

112

1235

(4211845)

769

0.94

0.20

3.6

3.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

761

1.06

0.20

1.6

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

761

1.06

0.20

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

761

1.06

0.20

1.6

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

140

1337

1.05

0.20

1.8

1.9

1.7

1.1

g/24h

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

606

1.07

0.20

1.1

4.5

79.1

819.7

mg/l

0.81

426

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

212

1.13

0.19

10.9

10.7

7.2

5.5

mmol/l

0.73

212

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.15

0.19

1.0

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.15

0.19

1.2

1.3

1.9

mg/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

118

1.19

0.19

1.1

—

(3025315) Body weight

118

1.19

0.19

6.1

4.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

763

1.06

0.19

3.8

3.7

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

602

0.93

0.19

1.5

1.4

57.2

63.7

0.76

490

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

950

0.95

0.18

2.1

1.7

—

(3015183) Erythrocyte sedimentation rate

512

1.07

0.18

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.19

0.18

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.17

0.17

1.4

1.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

216

0.88

0.17

1.3

43.9

371.9

u/l

0.89

156

(3004809) Band form neutrophils/100 leukocytes in Blood

244

2515

0.97

0.17

2.3

3.5

1.7

1.5

0.23

189

1939

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.13

0.17

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

1.22

0.17

1.4

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

763

0.94

0.17

2.6

40.6

37.8

0.42

263

(40758358) Immune stain study

0.74

0.17

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

361

0.91

0.16

2.0

1.5

8.8

9.0

ug/l

0.14

361

(3026470) Cobalt [Mass/volume] in Blood

1008

0.95

0.16

1.9

3.9

3.7

ug/l

0.09

885

(3004775) Volume in Urine collected for unspecified duration

117

1222

0.96

0.16

2.2

586.7

665.3

1.25

813

(40762814) Titanium [Mass/volume] in Blood

282

1.10

0.16

1.8

2.2

3.7

3.6

ug/l

—

105

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.18

0.16

22.3

12.4

395.1

320.7

e6/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

202

1957

1.03

0.16

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.20

0.16

1.1

1.3

1.1

u/field

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.79

0.15

6.5

3.4

—

(3025577) Chromium [Mass/volume] in Blood

985

0.95

0.15

1.9

2.0

2.3

ug/l

0.01

819

(3001893) Eosinophils/100 leukocytes in Pleural fluid

512

0.94

0.14

1.5

1.4

2.3

2.8

0.28

425

(3042111) Morphology [Interpretation] in Bone marrow Narrative

249

2554

0.97

0.14

1.3

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

522

0.94

0.14

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

382

1.07

0.14

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

136

1408

0.97

0.14

1.2

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

763

1.05

0.14

1.6

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

191

0.89

0.13

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

901

1.04

0.13

1.2

1.5

2.8

4.1

ug/l

1.31

746

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

268

2742

0.98

0.13

5.1

5.0

1608.8

1682.5

iu/ml

0.03

416

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

104

1081

0.96

0.13

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

107

0.84

0.13

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

499

0.94

0.12

1.3

39.7

39.8

g/l

0.02

258

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

190

1851

1.03

0.12

1.5

56.5

59.1

0.39

114

1159

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

146

1504

0.97

0.12

1.3

354.0

484.5

u/l

1.13

136

1423

(3041806) Other cells [#/volume] in Blood by Manual count

210

1.10

0.12

1.6

—

(3016750) Collection duration of Urine

876

1.04

0.11

2.1

494.7

501.4

min

0.23

636

(3000012) Reticulocyte production index

904

0.96

0.11

1.4

1.5

—

(3048879) Bone marrow aspiration report

476

0.95

0.11

1.3

1.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

445

1.06

0.11

1.3

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

485

0.95

0.10

2.3

1.8

19400.0

49587.9

u/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

607

0.96

0.10

1.7

2.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

193

1971

0.98

0.09

1.9

23.1

22.6

ug/l

0.05

188

1917

(3002256) Pathology report gross observation

1864

18531

1.01

0.09

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

311

1.06

0.09

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

360

1.06

0.09

1.2

1.3

39.2

35.7

0.19

239

(3041672) Baker's yeast Ab [Presence] in Serum

1.03

0.08

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

844

1.03

0.08

6.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.79

0.08

1.0

2.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

509

1.04

0.08

1.6

1.5

7.7

8.1

mmol/l

0.45

302

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.03

0.07

15.7

8.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.83

0.07

1.2

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.07

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.84

0.07

1.3

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.88

0.06

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

177

1.07

0.06

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

197

1.07

0.06

1.8

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

335

0.96

0.06

2.8

3.1

7.0

7.5

mg/l

0.19

271

(3017354) Segmented neutrophils/100 leukocytes in Blood

153

1553

0.99

0.05

2.3

3.5

62.6

58.3

1.54

101

1002

(3034426) Prothrombin time (PT)

424

0.97

0.05

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

744

1.02

0.04

1.1

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

893

8891

1.00

0.04

1.4

—

(3006462) Nitrate [Presence] in Urine

705

0.98

0.04

3.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

452

0.97

0.03

1.3

58.0

307.7

ug/l

1.74

238

(44786800) Granulocytes/100 leukocytes in Body fluid

220

1.05

0.03

1.3

43.8

22.8

1.30

170

(3042733) HLA Ab [Presence] in Serum

371

0.97

0.03

5.2

5.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

300

0.97

0.03

1.1

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

239

0.96

0.02

1.3

1.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

500

1.02

0.02

1.3

4.1

3.3

mmol/l

0.92

458

(3020393) Adenovirus Ag [Presence] in Stool

162

1.05

0.02

1.1

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

329

3276

1.00

0.02

4.5

3.4

7.3

7.7

mmol/l

2.35

324

3205

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

599

0.98

0.02

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

599

0.98

0.02

1.7

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

308

0.97

0.02

4.8

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

328

0.98

0.01

2.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

568

0.99

0.01

29.9

26.6

101.6

111.1

ug/l

0.78

472

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.06

0.01

1.0

0.6

0.2

u/ml

—

(21494815) CD4 cells/100 lymphocytes in Specimen

111

1103

1.01

0.00

2.2

2.1

46.3

41.2

0.72

134

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

134

1.04

0.00

1.9

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

304

1.02

0.00

1.4

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

139

1396

1.00

0.00

1.1

2.5

2.0

iu/ml

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

212

2114

1.00

0.00

2.5

401.2

5942.2

u/ml

—

135

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

324

0.99

0.00

1.7

1.9

9.2

mg/l

0.00

261

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

170

1.00

0.00

1.2

1.1

50.1

62.6

u/ml

0.33

162

(4133840)

323

0.99

0.00

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

392

0.99

0.00

2.1

1.8

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

135

1.04

0.00

1.4

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

112

0.98

0.00

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

514

0.99

0.00

38.8

33.5

6.9

7.2

ug/l

0.77

458

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

119

1190

1.00

0.00

1.3

12.7

13.9

u/l

0.44

107

1094

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.02

0.00

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

555

1.01

0.00

2.0

1.9

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

167

1.02

0.00

8.6

9.8

—

(3035880) pH of Pleural fluid

895

0.99

0.00

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

105

0.95

0.00

2.7

2.6

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.01

0.00

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

113

1132

1.00

0.00

1.8

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

679

1.00

0.00

1.3

5.8

5.9

mmol/l

1.01

643

(3045788) Cell count panel - Pleural fluid

153

1531

1.00

0.00

1.4

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

126

1.03

0.00

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

233

0.99

0.00

1.1

1.3

0.9

1.2

mmol/l

0.15

152

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.03

0.00

2.1

2.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.03

0.00

1.3

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

110

1.00

0.00

1.0

1.1

—

5.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

336

3357

1.00

0.00

1.5

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

163.8

—

(3001556) Androgen free Index in Serum or Plasma

0.88

0.00

1.7

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

9.6

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

36.9

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.01

0.00

1.0

1.1

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.4

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.93

0.00

1.0

0.0

0.4

u/ml

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.3

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.94

0.00

1.4

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.90

0.00

3.3

3.4

—

0.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_XTRAPYR and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_XTRAPYR	1.71 [1.58, 1.85]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.077

During the follow-up period (1.1.1998 — 31.12.2019), 15474 out of 49855 females with G6_XTRAPYR died.

Males

Parameter	HR [95% CI]	p-value
G6_XTRAPYR	1.859 [1.69, 2.04]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 17700 out of 44915 males with G6_XTRAPYR died.

Mortality risk

Mortality risk for people of age

years, who have G6_XTRAPYR.

N-year risk	Females	Males
1	0.202%	0.363%
5	0.939%	2.201%
10	2.404%	5.279%
15	4.468%	9.637%
20	7.572%	15.859%

Relationships between endpoints

↥

Index endpoint: G6_XTRAPYR – Extrapyramidal and movement disorders

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Extrapyramidal and movement disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints